<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">61951</article-id><article-id pub-id-type="doi">10.7554/eLife.61951</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>α-Synuclein plasma membrane localization correlates with cellular phosphatidylinositol polyphosphate levels</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-202755"><name><surname>Jacob</surname><given-names>Reeba Susan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0676-834X</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-202751"><name><surname>Eichmann</surname><given-names>Cédric</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8476-1936</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-202753"><name><surname>Dema</surname><given-names>Alessandro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0976-9396</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">‡</xref></contrib><contrib contrib-type="author" id="author-202754"><name><surname>Mercadante</surname><given-names>Davide</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6792-7706</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">§</xref></contrib><contrib contrib-type="author" corresp="yes" id="author-141250"><name><surname>Selenko</surname><given-names>Philipp</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2590-5899</contrib-id><email>philipp.selenko@weizmann.ac.il</email><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Department of Biological Regulation, Weizmann Institute of Science</institution><addr-line><named-content content-type="city">Rehovot</named-content></addr-line><country>Israel</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brunger</surname><given-names>Axel T</given-names></name><role>Reviewing Editor</role><aff><institution>Stanford University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Boudker</surname><given-names>Olga</given-names></name><role>Senior Editor</role><aff><institution>Weill Cornell Medicine</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>‡</label><p>UCSF, School of Dentistry, Department of Cell and Tissue Biology, San Francisco, United States</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>School of Chemical Sciences, University of Auckland, Auckland, New Zealand</p></fn><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>15</day><month>02</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e61951</elocation-id><history><date date-type="received" iso-8601-date="2020-08-10"><day>10</day><month>08</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-02-12"><day>12</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Jacob et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Jacob et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-61951-v2.pdf"/><abstract><p>The Parkinson’s disease protein α-synuclein (αSyn) promotes membrane fusion and fission by interacting with various negatively charged phospholipids. Despite postulated roles in endocytosis and exocytosis, plasma membrane (PM) interactions of αSyn are poorly understood. Here, we show that phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>) and phosphatidylinositol 3,4,5-trisphosphate (PIP<sub>3</sub>), two highly acidic components of inner PM leaflets, mediate PM localization of endogenous pools of αSyn in A2780, HeLa, SK-MEL-2, and differentiated and undifferentiated neuronal SH-SY5Y cells. We demonstrate that αSyn binds to reconstituted PIP<sub>2</sub> membranes in a helical conformation in vitro and that PIP<sub>2</sub> synthesizing kinases and hydrolyzing phosphatases reversibly redistribute αSyn in cells. We further delineate that αSyn-PM targeting follows phosphoinositide-3 kinase (PI3K)-dependent changes of cellular PIP<sub>2</sub> and PIP<sub>3</sub> levels, which collectively suggests that phosphatidylinositol polyphosphates contribute to αSyn’s function(s) at the plasma membrane.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>human cell lines</kwd><kwd>A2780</kwd><kwd>HeLa</kwd><kwd>SK-MEL-2</kwd><kwd>SH-SY5Y</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>647474</award-id><principal-award-recipient><name><surname>Selenko</surname><given-names>Philipp</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Swiss National Science Foundation</institution></institution-wrap></funding-source><award-id>P300PA_160979</award-id><principal-award-recipient><name><surname>Eichmann</surname><given-names>Cedric</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Plasma membrane clusters of the Parkinson's disease protein α-synuclein colocalize with negatively charged phospholipids involved in endocytosis and exocytosis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Aggregates of human α-synuclein (αSyn) constitute the main components of Lewy body inclusions in Parkinson’s disease (PD) and other synucleinopathies (<xref ref-type="bibr" rid="bib27">Goedert et al., 2013</xref>). In the brain, αSyn is abundantly found in different types of neurons, where it primarily localizes to presynaptic terminals and regulates synaptic vesicle (SV) clustering and trafficking (<xref ref-type="bibr" rid="bib72">Sulzer and Edwards, 2019</xref>). Isolated αSyn is disordered in solution, whereas residues 1–100 adopt extended or kinked helical conformations upon binding to membranes containing negatively charged phospholipids (<xref ref-type="bibr" rid="bib25">Fusco et al., 2018</xref>). Complementary electrostatic contacts between lysine residues within αSyn’s N-terminal KTKEGV-repeats and acidic phospholipid headgroups align these α-helices on respective membrane surfaces (<xref ref-type="bibr" rid="bib71">Snead and Eliezer, 2019</xref>). Membrane curvature (<xref ref-type="bibr" rid="bib52">Middleton and Rhoades, 2010</xref>), lipid packing defects (<xref ref-type="bibr" rid="bib57">Nuscher et al., 2004</xref>; <xref ref-type="bibr" rid="bib62">Pranke et al., 2011</xref>) and fatty acid compositions (<xref ref-type="bibr" rid="bib21">Fortin et al., 2004</xref>; <xref ref-type="bibr" rid="bib26">Galvagnion, 2017</xref>) act as additional determinants for membrane binding. αSyn remodels target membranes (<xref ref-type="bibr" rid="bib75">Varkey et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Westphal and Chandra, 2013</xref>), which likely relates to its biological function(s) in vesicle docking, fusion and fission (<xref ref-type="bibr" rid="bib72">Sulzer and Edwards, 2019</xref>). Furthermore, αSyn multimerization and aggregation may initiate at membrane surfaces, which holds important ramifications for possible cellular scenarios in PD (<xref ref-type="bibr" rid="bib26">Galvagnion, 2017</xref>). Early αSyn oligomers bind to and disrupt cellular and reconstituted membranes (<xref ref-type="bibr" rid="bib63">Reynolds et al., 2011</xref>; <xref ref-type="bibr" rid="bib24">Fusco et al., 2017</xref>), whereas mature aggregates are found closely associated with membranous cell structures and intact organelles in cellular models of Lewy body inclusions (<xref ref-type="bibr" rid="bib47">Mahul-Mellier et al., 2020</xref>) and in postmortem brain sections of PD patients (<xref ref-type="bibr" rid="bib70">Shahmoradian et al., 2019</xref>).</p><p>Phosphatidylinositol phosphates (PIPs) are integral components of cell membranes and a universal class of acidic phospholipids with key functions in biology (<xref ref-type="bibr" rid="bib3">Balla, 2013</xref>). Reversible phosphorylation of their inositol headgroups at positions 3, 4 and 5 generates seven types of PIPs, which act as selective binding sites for folded and disordered PIP-interaction domains (<xref ref-type="bibr" rid="bib2">Balla, 2005</xref>). In eukaryotic cells, PIPs make up less than 2% of total phospholipids with phosphatidylinositol 4,5-bisphosphate, PI(4,5)P<sub>2</sub> or PIP<sub>2</sub> hereafter, as the most common species (<xref ref-type="bibr" rid="bib50">McLaughlin et al., 2002</xref>). PIPs function as core determinants of organelle identity (<xref ref-type="bibr" rid="bib16">Di Paolo and De Camilli, 2006</xref>). PIP<sub>2</sub> is predominantly found at the inner leaflet of the plasma membrane (PM), where it acts as a signaling scaffold and protein-recruitment platform (<xref ref-type="bibr" rid="bib51">McLaughlin and Murray, 2005</xref>). Carrying a negative net charge of −4 at pH 7 renders it more acidic than other cellular phospholipids such as phosphatidylserine (net charge −1) or phosphatidic acid (net charge −1) (<xref ref-type="bibr" rid="bib40">Kooijman et al., 2009</xref>). Disordered PIP<sub>2</sub>-binding domains contain stretches of polybasic residues that establish complementary electrostatic contacts with the negatively charged PIP head groups (<xref ref-type="bibr" rid="bib50">McLaughlin et al., 2002</xref>) reminiscent of how αSyn KTKEGV-lysines interact with acidic phospholipids (<xref ref-type="bibr" rid="bib14">Dettmer, 2018</xref>). Indeed, αSyn has been shown to bind to reconstituted PIP<sub>2</sub> vesicles in vitro (<xref ref-type="bibr" rid="bib55">Narayanan et al., 2005</xref>). Phosphatidylinositol 3,4,5-trisphosphate, PI(3,4,5)P<sub>3</sub> or PIP<sub>3</sub> hereafter, harbors an additional phosphate group, which renders it even more acidic (net charge −5 at pH 7) (<xref ref-type="bibr" rid="bib40">Kooijman et al., 2009</xref>). The steady-state abundance of PIP<sub>3</sub> at the PM is low (<xref ref-type="bibr" rid="bib3">Balla, 2013</xref>), but local levels increase dynamically in response to cell signaling, especially following phosphatidylinositide-3 kinase (PI3K) activation (<xref ref-type="bibr" rid="bib7">Bilanges et al., 2019</xref>).</p><p>Here, we set out to investigate whether native αSyn interacted with PM PIP<sub>2</sub> and PIP<sub>3</sub> in mammalian cells. Using confocal and total internal reflection fluorescence (TIRF) microscopy, we show that endogenous αSyn forms discrete foci at the PM of human A2780, HeLa, SK-MEL-2 and neuronal SH-SY5Y cells. The abundance and localization of these foci correlate with pools of PM PIP<sub>2</sub> and PIP<sub>3</sub>. We further delineate high-resolution insights into αSyn interactions with reconstituted PIP<sub>2</sub> vesicles by nuclear magnetic resonance (NMR) spectroscopy and establish that αSyn binds PIP<sub>2</sub> membranes in its characteristic, helical conformation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>PM localization of endogenous αSyn</title><p>To determine the intracellular localization of αSyn, we selected a panel of human cell lines (A2780, HeLa, SH-SY5Y and SK-MEL-2) that expressed low but detectable amounts of the endogenous protein. Confocal immunofluorescence (IF) localization in A2780 cells with an antibody that specifically recognizes αSyn without cross-reacting with its β and γ isoforms (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) revealed a speckled intracellular distribution with distinct αSyn foci at apical and basal PM regions (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We verified overall antibody specificity by downregulating αSyn expression via siRNA-mediated gene silencing, which established that αSyn foci corresponded to endogenous protein pools (<xref ref-type="fig" rid="fig1">Figure 1B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>). To investigate colocalization of αSyn and PIP<sub>2</sub>, we co-stained A2780 cells with αSyn and PIP<sub>2</sub> antibodies, and imaged basal PM planes by IF microscopy (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, top panel). In 10–20% of cases, we detected clear superpositions of αSyn and PIP<sub>2</sub> signals, which we confirmed by measuring fluorescence intensity profiles over individual cell cross-sections (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, top panel). We verified PM colocalization of αSyn with PIP<sub>2</sub> in SH-SY5Y cells that we differentiated into dopaminergic-like neurons following a stringent protocol and stimulation with retinoic acid (RA) and brain-derived neurotrophic factor (BDNF) (<xref ref-type="bibr" rid="bib20">Encinas et al., 2000</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>, <xref ref-type="supplementary-material" rid="fig1s1sdata2">Figure 1—figure supplement 1—source data 2</xref>). We found prominent pools of αSyn in expanded structures reminiscent of synaptic boutons along neurites, where they colocalized with PIP<sub>2</sub> (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, bottom panel, <xref ref-type="fig" rid="fig1">Figure 1D</xref>, and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). These structures also stained positive for the presynaptic V-SNARE component syanptobrevin-2/VAMP2, a known binding partner of αSyn (<xref ref-type="bibr" rid="bib11">Burré et al., 2010</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Plasma membrane (PM) localization of endogenous α-synuclein (αSyn).</title><p>(<bold>A</bold>) Immunofluorescence detection of endogenous αSyn in A2780 cells by confocal microscopy. PM stained with tetramethylrhodamine-wheat germ agglutinin (WGA) (left panel) or identified via GFP-PLCδ-PH (right panel). Representative apical and basal confocal planes are shown. Scale bars are 2 μm (left) and 10 μm (right). (<bold>B</bold>) αSyn-PM localization in A2780 cells following control (si NT) and targeted siRNA (si αSyn) knockdown. Phalloidin staining of F-actin marks cell boundaries. Scale bars are 10 μm. (<bold>C</bold>) Immunofluorescence detection of endogenous αSyn and phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>) at the PM in A2780 (top) and differentiated SH-SY5Y cells (bottom). Scale bars are 5 μm. (<bold>D</bold>) Spatially resolved αSyn (green) and PIP<sub>2</sub> (red) fluorescence intensity profiles across the dotted lines in the closeup views. Resolved αSyn and PIP<sub>2</sub> traces are marked with arrowheads. (<bold>E</bold>) αSyn-PM localization and quantification after transient green fluorescent protein (GFP) or GFP-PIPKIγ overexpression in A2780 and undifferentiated SH-SY5Y cells. GFP fluorescence identifies transfected cells. Scale bars are 10 μm. Box plots for αSyn immunofluorescence quantification. Data points represent n ~120 cells collected in four independent replicate experiments. Box dimensions represent the 25th and 75th percentiles, whiskers extend to the 5th and 95th percentiles. Data points beyond these values were considered outliers. Significance based on Student’s <italic>t</italic> tests as ∗∗∗p&lt;0.001. See also <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>.</p><p> <supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw data of αSyn PM localization upon PIPKinase expression.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>αSyn siRNA knockdown, differentiation of SH-SY5Y cells and αSyn, PI(4,5)P2 and synaptobrevin 2/VAMP2 colocalization.</title><p>(<bold>A</bold>) Western blot to determine the specificity of the α-synuclein (αSyn) antibody (sc69977) against β and γ isoforms of the protein. (<bold>B</bold>) Western blot of A2780 lysates of control (si NT) and targeted siRNA (si αSyn) knockdown cells. Recombinant N-terminally acetylated αSyn serves as input, β-actin as loading controls. See also <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>. (<bold>C</bold>) Bright field microscopy images of the SH-SY5Y differentiation time course upon retinoic acid treatment (5 days) followed by brain-derived neurotrophic factor (BDNF) stimulation (7 days). Respective days (D0 to D12) are indicated. Western blot of endogenous αSyn concentrations in SH-SY5Y lysates during the differentiation time course with recombinant αSyn as input, β-actin as loading controls. See also <xref ref-type="supplementary-material" rid="fig1s1sdata2">Figure 1—figure supplement 1—source data 2</xref>. (<bold>D</bold>) Closeup views of αSyn-PIP<sub>2</sub> colocalizations in A2780 (left) and differentiated SH-SY5Y cells (right) as in <xref ref-type="fig" rid="fig1">Figure 1B</xref>. Arrowheads mark prominent sites. (<bold>E</bold>) Colocalization of αSyn and synaptobrevin-2/VAMP2 in neurites of day 14 differentiated SH-SY5Y cells. Scale bar is 10 μm. PIP<sub>2</sub>: phosphatidylinositol 4,5-bisphosphate. DMEM: Dulbecco's modified eagle medium. FBS: Fetal bovine serum. RA: Retinoic acid. </p><p> <supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Uncropped western blots of αSyn siRNA knockdown.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-61951-fig1-figsupp1-data1-v2.pdf"/></supplementary-material> </p><p> <supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Uncropped western blots of endogenous αSyn levels upon differentiation of SH-SY5Y cells.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-61951-fig1-figsupp1-data2-v2.pdf"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>αSyn PM localization in A2780, HeLa, undifferentiated SH-SY5Y and SK-MEL-2 cells.</title><p>(<bold>A</bold>) Immunofluorescence localization and quantification of endogenous α-synuclein (αSyn) in HeLa cells transfected with green fluorescent protein (GFP) or GFP-PIPKIγ. Scale bar is 10 μm. Box plots for αSyn immunofluorescence quantification. Data points represent n ~ 120 cells collected in four independent replicate experiments. Box dimensions represent the 25th and 75th percentiles, whiskers extend to the 5th and 95th percentiles. Data points beyond these values were considered outliers. Significance based on Student’s <italic>t</italic> tests as ∗∗∗p&lt;0.001. See also <xref ref-type="supplementary-material" rid="fig1s2sdata1">Figure 1—figure supplement 2—source data 1</xref>. (<bold>B</bold>) Lysate western blots of endogenous αSyn in A2780 and undifferentiated SH-SY5Y cells transiently transfected with indicated PIPKIγ expression plasmids. Control (ctrl), mock and GFP-only transfected cells serve as baseline controls. Wild-type (WT) and kinase-inactive D316A- and K188A-PIPKIγ mutants were used to assess possible differences between kinase activity versus PM-targeting effects on αSyn levels. See also <xref ref-type="supplementary-material" rid="fig1s2sdata2">Figure 1—figure supplement 2—source data 2</xref>. (<bold>C</bold>) Total internal reflection fluorescence (TIRF) microscopy of αSyn-PM localization in A2780, HeLa, SH-SY5Y and SK-MEL-2 cells. Plasma membrane (PM) stained with tetramethylrhodamine-wheat germ agglutinin (WGA). Scale bars are 10 μm. Western blot of endogenous αSyn in respective cell lysates. Recombinant N-terminally acetylated αSyn serves as input, β-actin as loading controls. Bar graphs denote western blot quantifications of αSyn with signals normalized against β-actin. Error bars denote standard deviations based on measured background. See also <xref ref-type="supplementary-material" rid="fig1s2sdata3">Figure 1—figure supplement 2—source data 3</xref>.</p><p> <supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Quantification of αSyn PM levels upon GFP and GFP-PIPKIγ expression in HeLa cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig1-figsupp2-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig1s2sdata2"><label>Figure 1—figure supplement 2—source data 2.</label><caption><title>Uncropped western blots of endogenous αSyn levels upon PIPKIγ expression.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-61951-fig1-figsupp2-data2-v2.pdf"/></supplementary-material> </p><p> <supplementary-material id="fig1s2sdata3"><label>Figure 1—figure supplement 2—source data 3.</label><caption><title>Uncropped western blot of endogenous αSyn levels in A2780, HeLa, undifferentiated SH-SY5Y and SK-MEL-2 cells.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-61951-fig1-figsupp2-data3-v2.pdf"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig1-figsupp2-v2.tif"/></fig></fig-group><p>To test whether changes in cellular PIP<sub>2</sub> levels affected αSyn abundance at the PM, we transiently overexpressed green fluorescent protein (GFP)-tagged phosphatidylinositol-4-phosphate 5-kinase PIPKIγ (<xref ref-type="bibr" rid="bib41">Krauss et al., 2006</xref>). PIPKIγ localizes to the PM via a unique di-lysine motif in its activation loop (<xref ref-type="bibr" rid="bib43">Kunz et al., 2000</xref>). Upon kinase expression, confirmed by GFP fluorescence, we detected increased amounts of αSyn at the PM of transfected cells (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). By contrast, expression of GFP alone did not alter PM levels of αSyn. We obtained similar results in undifferentiated SH-SY5Y and HeLa cells (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>, <xref ref-type="supplementary-material" rid="fig1s2sdata1">Figure 1—figure supplement 2—source data 1</xref>) and confirmed that transient PIPKIγ expression did not affect overall αSyn abundance (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>, <xref ref-type="supplementary-material" rid="fig1s2sdata2">Figure 1—figure supplement 2—source data 2</xref>). These findings suggested that PM localization of endogenous αSyn correlated with cellular PIP<sub>2</sub> levels. To better resolve the presence of αSyn at the PM, we resorted to TIRF microscopy. Employing a narrow evanescent field depth of ~50 nm, we detected endogenous αSyn at PM foci in A2780, HeLa, SH-SY5Y and SK-MEL-2 cells, which correlated with total αSyn levels determined by semi-quantitative western blotting (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>, <xref ref-type="supplementary-material" rid="fig1s2sdata3">Figure 1—figure supplement 2—source data 3</xref>). Importantly, both imaging approaches were targeted toward detecting PM pools of αSyn and did not aim at interrogating cytoplasmic fractions of the endogenous protein.</p></sec><sec id="s2-2"><title>αSyn binds reconstituted PIP<sub>2</sub> vesicles</title><p>To test whether αSyn directly bound PIP<sub>2</sub> membranes under physiological salt and pH conditions (150 mM, pH 7.0), we added N-terminally acetylated, <sup>15</sup>N isotope-labeled αSyn to reconstituted PIP<sub>2</sub> vesicles. Circular dichroism (CD) spectroscopy revealed characteristic helical signatures (<xref ref-type="bibr" rid="bib13">Davidson et al., 1998</xref>; <xref ref-type="bibr" rid="bib35">Jo et al., 2000</xref>; <xref ref-type="fig" rid="fig2">Figure 2A</xref>), whereas NMR experiments confirmed site-selective line broadening of N-terminal residues 1–100, confirming membrane binding (<xref ref-type="bibr" rid="bib10">Bodner et al., 2009</xref>; <xref ref-type="bibr" rid="bib17">Dikiy and Eliezer, 2014</xref>; <xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>). In line with these observations, we detected remodeled PIP<sub>2</sub> vesicles by negative-stain transmission electron microscopy (EM), manifested by tubular extrusions emanating from reconstituted specimens and agreeing with published findings on other membrane systems (<xref ref-type="bibr" rid="bib75">Varkey et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Westphal and Chandra, 2013</xref>; <xref ref-type="fig" rid="fig2">Figure 2A</xref>). Together, these results established that residues 1–100 of αSyn interacted with PIP<sub>2</sub> vesicles in helical conformations that imposed membrane remodeling, whereas its 40 C-terminal residues did not engage in membrane binding and remained flexible and disordered. To gain further insights into αSyn-PIP<sub>2</sub> interactions, we reconstituted phosphatidylcholine (PC)-PIP<sub>2</sub> vesicles (100 nm diameter) at a fixed molar ratio of 13:1 (PC:PIP<sub>2</sub>) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). We added increasing amounts of these PC-PIP<sub>2</sub> vesicles to αSyn and measured CD and dynamic light scattering (DLS) spectra of the resulting mixtures. Up to a ~50-fold molar excess of lipid to protein, αSyn interacted with PC-PIP<sub>2</sub> vesicles in a helical conformation without disrupting the monodisperse nature of the specimens, that is, without membrane remodeling (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). In parallel, we performed NMR experiments on these samples and measured intensity changes of αSyn resonances in a residue-resolved manner (<xref ref-type="fig" rid="fig2">Figure 2D</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>, <xref ref-type="supplementary-material" rid="fig2s2sdata1">Figure 2—figure supplement 2—source data 1</xref>). Analyzing signal intensity ratios (I/I<sub>0</sub>) of unbound (I<sub>0</sub>) and PC-PIP<sub>2</sub>-bound αSyn (I), we found that residues 1–10 constituted the primary interaction sites, whereas residues 11–100 displayed progressively weaker membrane contacts. In agreement with our experiments on PIP<sub>2</sub>-only vesicles, we detected no contributions by C-terminal αSyn residues. These findings confirmed the tri-segmental nature of αSyn-PIP<sub>2</sub> interactions and the importance of anchoring contacts by N-terminal αSyn residues, similar to other membrane systems (<xref ref-type="bibr" rid="bib10">Bodner et al., 2009</xref>; <xref ref-type="bibr" rid="bib22">Fusco et al., 2014</xref>; <xref ref-type="bibr" rid="bib23">Fusco et al., 2016</xref>). To further validate our conclusions, we performed NMR experiments with mutant forms of αSyn in which we deleted residues 1–4 (ΔN) (<xref ref-type="bibr" rid="bib4">Bartels et al., 2010</xref>), substituted Phe4 and Tyr39 with alanine (F4A-Y39A) (<xref ref-type="bibr" rid="bib46">Lokappa et al., 2014</xref>), or oxidized αSyn Met1, Met5, Met116 and Met123 to methionine-sulfoxides (MetOx) (<xref ref-type="bibr" rid="bib48">Maltsev et al., 2013</xref>; <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>). In line with earlier reports, we did not observe binding to PC-PIP<sub>2</sub> vesicles for any of these variants. Our results corroborated that PC-PIP<sub>2</sub> interactions strongly depended on intact N-terminal αSyn residues, with critical contributions by Phe4 and Tyr39, and requiring Met1 and Met5 in their reduced states.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>α-Synuclein (αSyn) binding to reconstituted phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>) vesicles.</title><p>(<bold>A</bold>) Circular dichroism (CD) spectrum and negative-stain electron micrograph of αSyn-bound PIP<sub>2</sub> vesicles (100%). Scale bar is 100 nm. (<bold>B</bold>) Overlay of 2D <sup>1</sup>H-<sup>15</sup>N nuclear magnetic resonance (NMR) spectra of isolated αSyn in buffer (black) and bound to PIP<sub>2</sub> vesicles (green). Remaining signals of C-terminal αSyn residues are labeled. (<bold>C</bold>) CD spectra of αSyn bound to phosphatidylcholine (PC)-PIP<sub>2</sub> vesicles at increasing lipid-to-protein ratios (inset) and negative-stain electron micrograph of the αSyn:PC-PIP<sub>2</sub> (1:50 protein:PIP<sub>2</sub>) sample. Scale bar is 100 nm. (<bold>D</bold>) NMR signal intensity ratios of bound (I) over unbound (I<sub>0</sub>) αSyn in the presence of different amounts of PC-PIP<sub>2</sub> vesicles (equivalent to (<bold>C</bold>)). Only residues 1–40 are shown. (<bold>E</bold>) I/I<sub>0</sub> of PC-PIP<sub>2</sub> bound αSyn at 1:50 (green) and after addition of phospholipase C (PLC) (dark gray) and Ca<sup>2+</sup> (light gray). Selected regions of 2D <sup>1</sup>H-<sup>15</sup>N NMR spectra of PC-PIP<sub>2</sub> bound αSyn (left, green) and in the presence of PLC (top right, dark gray) and Ca<sup>2+</sup> (bottom right, light gray). Release of N-terminal αSyn residues from vesicles and reappearance of corresponding NMR signals are indicated for Asp2 (D2) as an example. (<bold>F</bold>) Hydrodynamic diameters of αSyn-bound PC-PIP<sub>2</sub> vesicles before (green) and after PLC (dark gray) and Ca<sup>2+</sup> (light gray) addition by dynamic light scattering. Errors were calculated based on measurements on three independent replicate samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>NMR characterization of αSyn binding to reconstituted PI(4,5)P2 vesicles.</title><p>(<bold>A</bold>) Overlay of 2D <sup>1</sup>H-<sup>15</sup>N nuclear magnetic resonance (NMR) spectra of isolated, N-terminally acetylated α-synuclein (αSyn) (black) and bound to a 30-fold molar excess of phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>)-only vesicles (green). Uniform signal broadening of N-terminal residues 1–100 is evident. Observable C-terminal αSyn signals are labeled. (<bold>B</bold>) Selected region of 2D <sup>1</sup>H-<sup>15</sup>N NMR spectra of αSyn upon addition of increasing amounts of PIP<sub>2</sub>-only vesicles, corresponding to molar protein:lipid ratios of 1:1, 1:5, 1:10, 1:15, 1:20 and 1:30, with Met1 (M1) labeled in green and Glu137 (E137) indicated in orange. Note that Ala107 (A107, red) at the border between membrane-bound (N-terminal) and -unbound (C-terminal) αSyn residues displays peak-splitting at increasing PIP<sub>2</sub> concentrations, indicative of chemical shift differences between free and membrane-bound protein states. (<bold>C</bold>) Residue-resolved signal attenuation profiles (I/I<sub>0</sub>) of free (I<sub>0</sub>) versus PIP<sub>2</sub> bound αSyn (I) at previously indicated molar ratios. Positions of C-terminal αSyn proline residues without peptide amide resonances are shown in the three-letter amino acid code. See also <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>.</p><p> <supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>NMR signal intensity ratios of αSyn binding to PI(4,5)P2 vesicles.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>NMR characterization of αSyn binding to reconstituted PC-PI(4,5)P2 vesicles.</title><p>(<bold>A</bold>) Hydrodynamic diameters of phosphatidylcholine-phosphatidylinositol 4,5-bisphosphate (PC-PIP<sub>2</sub>) vesicles in the absence (dashed gray) and presence of α-synuclein (αSyn) (green) at a protein:lipid ratio of 1:50 by dynamic light scattering . Errors were calculated based on measurements of three independent replicate samples. (<bold>B</bold>) Selected regions of 2D <sup>1</sup>H-<sup>15</sup>N nuclear magnetic resonance (NMR) spectra of isolated, N-terminally acetylated αSyn (black) and in the presence of 6, 13, 25 and 50 mol equivalents of PC-PIP<sub>2</sub> vesicles (blue to green). Site-selective line broadening of N-terminal residues 1–9 is highlighted. Residue-resolved signal attenuation profiles (I/I<sub>0</sub>) of free (I<sub>0</sub>) versus PC-PIP<sub>2</sub> bound αSyn (I) at previously indicated molar ratios. Positions of C-terminal αSyn proline residues without peptide amide resonances are shown in the three-letter amino acid code. See also <xref ref-type="supplementary-material" rid="fig2s2sdata1">Figure 2—figure supplement 2—source data 1</xref>. </p><p> <supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>NMR signal intensity ratios of αSyn binding to PC-PI(4,5)P2 vesicles.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig2-figsupp2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>NMR characterization of mutant αSyn binding to reconstituted PC-PI(4,5)P2 vesicles and upon phospholipase C (PLC) treatment.</title><p>(<bold>A</bold>) Selected regions of 2D <sup>1</sup>H-<sup>15</sup>N nuclear magnetic resonance (NMR) spectra. Left to right: Overlay of isolated, N-terminally acetylated wild-type (WT) α-synuclein (αSyn) and bound to phosphatidylcholine-phosphatidylinositol 4,5-bisphosphate (PC-PIP<sub>2</sub>) vesicles at a protein:lipid ratio of 1:50 (green). NMR spectra of N-terminally truncated αSyn lacking residues 1–4 (ΔN), mutated (F4A-Y39A), and methionine-oxidized (MetOx) αSyn in the presence of PC-PIP<sub>2</sub> vesicles (1:50). (<bold>B</bold>) Chemical structures and reaction scheme of phospholipase C (PLC)-mediated PIP<sub>2</sub> hydrolysis. (<bold>C</bold>) Overlay of selected regions of 2D <sup>1</sup>H-<sup>15</sup>N NMR spectra of αSyn bound to PC-PIP<sub>2</sub> vesicles (1:50) before (green) and after PLC hydrolysis (dark gray). N-terminal residues 1–9 are highlighted. Corresponding residue-resolved signal attenuation profiles (I/I<sub>0</sub>) of free versus PC-PIP<sub>2</sub> vesicle-bound αSyn before (green) and after PLC hydrolysis (dark gray). Positions of C-terminal αSyn proline residues without peptide amide resonances are shown in the three-letter amino acid code. See also <xref ref-type="supplementary-material" rid="fig2s3sdata1">Figure 2—figure supplement 3—source data 1</xref>.</p><p> <supplementary-material id="fig2s3sdata1"><label>Figure 2—figure supplement 3—source data 1.</label><caption><title>NMR signal intensity ratios of αSyn binding to PC-PI(4,5)P2 vesicles upon phospholipase C (PLC) treatment.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig2-figsupp3-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>NMR characterization of αSyn binding to reconstituted PC-PI(4,5)P2 vesicles in the presence of Ca and inositol polyphosphate (IP6) interaction.</title><p>(<bold>A</bold>) Overlay of 2D <sup>1</sup>H-<sup>15</sup>N nuclear magnetic resonance (NMR) spectra of phosphatidylcholine-phosphatidylinositol 4,5-bisphosphate (PC-PIP<sub>2</sub>) vesicle-bound α-synuclein (αSyn) in the absence (green) and presence of Ca<sup>2+</sup> (light gray). Residue-resolved NMR signal intensity ratios (I/I<sub>0</sub>) of free versus PC-PIP<sub>2</sub> vesicle-bound αSyn with (light gray) and without Ca<sup>2+</sup> (green). Positions of C-terminal αSyn proline residues without peptide amide resonances are shown in the three-letter amino acid code. See also <xref ref-type="supplementary-material" rid="fig2s4sdata1">Figure 2—figure supplement 4—source data 1</xref>. (<bold>B</bold>) Hydrodynamic diameters of PC-PIP<sub>2</sub> vesicles (dashed black) and in the presence of Ca<sup>2+</sup> (light gray) or phospholipase C (PLC) (dark gray) by dynamic light scattering . Errors were calculated based on measurements of three independent replicate samples. (<bold>C</bold>) Overlay of 2D <sup>1</sup>H-<sup>15</sup>N NMR spectra of αSyn (black) and in the presence of a fourfold molar excess of free inositol polyphosphate (IP<sub>6</sub>, orange). N-terminal residues 1–9 are highlighted. Slight changes in sample pH toward a more acidic value are indicated by the chemical shift change of His50 (H50).</p><p> <supplementary-material id="fig2s4sdata1"><label>Figure 2—figure supplement 4—source data 1.</label><caption><title>NMR signal intensity ratios of αSyn binding to PC-PI(4,5)P2 vesicles upon Ca addition.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig2-figsupp4-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig2-figsupp4-v2.tif"/></fig></fig-group><p>In contrast to other lipids, PIPs offer attractive means to regulate the reversibility of αSyn-membrane interactions. Different charge states of PIPs can be generated from phosphatidylinositol (PI) precursors by action of PIP kinases and phosphatases (<xref ref-type="bibr" rid="bib49">Matteis and Godi, 2004</xref>), or via PIP conversion by lipases such as phospholipase C (PLC) to produce soluble inositol 1,4,5-trisphosphate (IP<sub>3</sub>) and diacylglycerol (<xref ref-type="bibr" rid="bib5">Berridge and Irvine, 1984</xref>; <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref>). To investigate the reversibility of αSyn-PIP<sub>2</sub> interactions, we prepared PC-PIP<sub>2</sub> vesicles bound to <sup>15</sup>N isotope-labeled αSyn to which we added catalytic amounts of unlabeled PLC. We reasoned that PLC will progressively hydrolyze PIP<sub>2</sub> binding sites and, concomitantly, release αSyn. In turn, we expected to observe an increase of αSyn NMR signals corresponding to the fraction of accumulating, unbound protein molecules. Indeed, we detected the recovery of αSyn NMR signals upon PLC addition (<xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3C</xref>, <xref ref-type="supplementary-material" rid="fig2s3sdata1">Figure 2—figure supplement 3—source data 1</xref>). Next, we asked whether αSyn binding to PC-PIP<sub>2</sub> vesicles was sensitive to calcium, a competitive inhibitor of many protein-PIP<sub>2</sub> interactions (<xref ref-type="bibr" rid="bib8">Bilkova et al., 2017</xref>). Whereas overall binding was greatly reduced, we found that the first 10 residues of αSyn displayed residual anchoring contacts with PC-PIP<sub>2</sub> vesicles even at high (2.5 mM) calcium concentrations (<xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4A</xref>, <xref ref-type="supplementary-material" rid="fig2s4sdata1">Figure 2—figure supplement 4—source data 1</xref>), confirming earlier results on the stability of αSyn PC-PIP<sub>2</sub> vesicle interactions in the presence of calcium (<xref ref-type="bibr" rid="bib55">Narayanan et al., 2005</xref>). Notably, DLS measurements showed that hydrodynamic diameters of PC-PIP<sub>2</sub> vesicles expanded upon PLC treatment and in the presence of calcium, irrespective of whether αSyn was bound (<xref ref-type="fig" rid="fig2">Figure 2F</xref> and <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4B</xref>). This further suggested that vesicle remodeling and concomitant curvature reductions did not abolish αSyn interactions. Finally, we sought to determine whether electrostatic interactions with acidic PIP headgroups alone mediated αSyn binding. To this end, we added a fourfold molar excess of free inositol polyphosphate (IP<sub>6</sub>) to <sup>15</sup>N isotope-labeled αSyn. Surprisingly, we did not detect binding of αSyn to this highly negatively charged entity (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4C</xref>), which insinuated that αSyn interactions with PIP-containing membranes required additional lipid contributions besides headgroup contacts.</p></sec><sec id="s2-3"><title>αSyn-PM localization correlates with changes in PIP<sub>2</sub>-PIP<sub>3</sub> levels</title><p>Following these results, we asked whether reversible αSyn-PIP<sub>2</sub> interactions were present in cells. To answer this question, we transiently overexpressed different PM-targeted PIP phosphatases in A2780 cells and quantified PM localization of endogenous αSyn by confocal IF microscopy (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Specifically, we expressed MTM1-mCherry-CAAX, which hydrolyzes PI(3)P to yield PI, INPP5E-mCherry-CAAX to produce PI(4)P from PIP<sub>2</sub> and PTEN-mCherry-CAAX to create PIP<sub>2</sub> from PI(3,4,5)P<sub>3</sub>, as described (<xref ref-type="bibr" rid="bib61">Posor et al., 2013</xref>). In agreement with our hypothesis, only the conversion of PIP<sub>2</sub> to PI(4)P by INPP5E led to a marked reduction of endogenous αSyn at the PM (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Together with earlier kinase results, these findings corroborated that PM localization of cellular αSyn was modulated by PIP<sub>2</sub>-specific enzymes. Next, we asked whether signaling-dependent activation of PI3K and concomitant accumulations of the even more negatively charged PIP<sub>3</sub> (<xref ref-type="bibr" rid="bib7">Bilanges et al., 2019</xref>) led to dynamic changes of αSyn abundance at the PM. To this end, we employed histamine stimulation of SK-MEL-2 cells that we transiently co-transfected with histamine 1 receptor 1 (H1R) and a PH-domain GFP-fusion construct of the general receptor of phosphoinositides 1 (GRP1) that specifically interacts with membrane PIP<sub>3</sub> (<xref ref-type="bibr" rid="bib39">Kavran et al., 1998</xref>). Because histamine-mediated PI3K activation also induces time-dependent secondary effects including PIP<sub>2</sub> hydrolysis by PLC (<xref ref-type="bibr" rid="bib65">Saheki et al., 2016</xref>), we monitored αSyn localization and PIP<sub>2</sub>-PIP<sub>3</sub> levels in a time-resolved fashion by fixing SK-MEL-2 cells at 40, 85, 120, and 240 s after histamine addition (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="supplementary-material" rid="fig3sdata2">Figure 3—source data 2</xref>). After 40 s, we observed an initial increase of PIP<sub>2</sub> and PIP<sub>3</sub> levels at the PM, which was mirrored by greater pools of endogenous αSyn at basal membrane regions. While PIP<sub>2</sub> levels dropped at intermediate time points (85–120 s), likely due to PLC-mediated PIP<sub>2</sub> hydrolysis, PIP<sub>3</sub> concentrations were highest at 85 s and leveled off more slowly (120–240 s). Interestingly, PM-αSyn followed the observed PIP<sub>3</sub> behavior in a remarkably similar manner. At later time points (240 s), we noted a significant redistribution of cellular PIP<sub>2</sub> and PIP<sub>3</sub> pools toward the edges of SK-MEL-2 cells, coinciding with the accumulation of bundled actin fibers and in line with expected PI3K-signaling-dependent rearrangements of the cytoskeleton (<xref ref-type="bibr" rid="bib7">Bilanges et al., 2019</xref>). αSyn colocalization with these peripheral PIP<sub>2</sub>-PIP<sub>3</sub> speckles was significantly higher than at earlier time points (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). We independently confirmed these results with single time point measurements by TIRF microscopy (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>). To investigate whether other PI3K pathways caused similar effects, we stimulated SK-MEL-2 with insulin, which triggers PI3K activation via receptor tyrosine kinase signaling (<xref ref-type="bibr" rid="bib64">Ruderman et al., 1990</xref>). We verified that SK-MEL-2 cells endogenously expressed the insulin-like growth factor-1 receptor β (IGF-1 Rβ) by western blotting (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>, <xref ref-type="supplementary-material" rid="fig3s1sdata2">Figure 3—figure supplement 1—source data 2</xref>). In support of our hypothesis, we measured increased αSyn-PM localization by TIRF microscopy upon insulin stimulation for 10 min (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>, <xref ref-type="supplementary-material" rid="fig3s1sdata3">Figure 3—figure supplement 1—source data 3</xref>). Given the short exposure times to histamine and insulin in these experiments, we reasoned that observed PM accumulations likely reflected enhanced recruitment of existing αSyn pools rather than de novo protein synthesis and PM targeting, thus providing further evidence that αSyn abundance at the PM correlated with signaling-dependent changes of PIP<sub>2</sub> and PIP<sub>3</sub> levels.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Reversible α-synuclein (αSyn)-plasma membrane (PM) localization.</title><p>(<bold>A</bold>) Representative immunofluorescence localization of αSyn at basal A2780 PM planes by confocal microscopy. Cells transiently expressing PM-targeted, mCherry-tagged phosphatidylinositol phosphate (PIP) phosphatases, with mCherry fluorescence indicating successful transfection and phosphatase expression. Mutant, phosphatase-inactive INPP4A-mCherry-CAAX serves as the negative control (mCherry-ctrl, first panel). Scale bar is 10 μm. Box plots of αSyn immunofluorescence quantifications are shown on the right. Approximately 120 data points were collected per cell in four independent replicate experiments. Box dimensions represent the 25th and 75th percentiles, whiskers extend to the 5th and 95th percentiles. Data points beyond these values were considered outliers. Significance based on analysis of variance (ANOVA) tests with Bonferroni’s post-tests as NS &gt;0.05; ∗p&lt;0.05; ∗∗∗p&lt;0.001. See also <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>. (<bold>B</bold>) Time-course experiments following histamine stimulation of SK-MEL-2 cells transiently expressing histamine 1 receptor (H1R) and GRP1-PH. Immunofluorescence detection of endogenous phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>) and αSyn by confocal microscopy of basal PM regions. GRP1-PH GFP-signals report on the presence of PIP<sub>3</sub>. Phalloidin staining of F-actin marks cell boundaries. Scale bar is 10 μm. Box plots represent data points collected per cell (n ~ 80) from a single experiment, but representative of three independent experiments with similar results. Significance based on ANOVA tests with Bonferroni’s post-tests as NS &gt;0.05; ∗p&lt;0.05; ∗∗p&lt;0.01; ∗∗∗p&lt;0.001. See also <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p> <supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Quantification of αSyn PM localization following PIP phosphatase expression.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig3-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Quantification of αSyn PM localization after histamine stimulation.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig3-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Dynamic αSyn plasma-membrane (PM) localization upon histamine and insulin stimulation.</title><p>(<bold>A</bold>) Spatially resolved fluorescence intensity profiles of α-synuclein (αSyn, green), phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>,red), and GRP1-PH (PIP<sub>3</sub>, blue) at the plasma membrane (PM) at indicated time points following histamine stimulation. Individual traces span extracellular and intracellular portions of analyzed cells. PM regions are indicated by gray boxes. (<bold>B</bold>, <bold>D</bold>) Immunofluorescence localization of endogenous αSyn in SK-MEL-2 cells by total internal reflection (TIRF) microscopy counterstained with Phalloidin for F-actin to mark cell boundaries. Cells were stimulated with histamine (<bold>B</bold>) or insulin (<bold>D</bold>). Quantification of αSyn signals at basal PM regions with and without stimulation shown on the right. Box plots represent data points collected from n~120 cells combined from three independent replicate experiments. Significance based on Student’s <italic>t</italic> tests as ∗∗p&lt;0.01; ∗∗∗p&lt;0.001. Scale bars are 10 μm. See also <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig3s1sdata3">3</xref>. (<bold>C</bold>) Western blot of SK-MEL-2 and HEK 293 cell lysates showing the presence of endogenous insulin-like growth factor-1 receptor β (IGF-1 Rβ). β-Actin serves as loading control. See also <xref ref-type="supplementary-material" rid="fig3s1sdata2">Figure 3—figure supplement 1—source data 2</xref>. PIP<sub>3</sub>: phosphatidylinositol 3,4,5-trisphosphate.</p><p> <supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Quantification of αSyn PM localisation after histamine stimulation.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Uncropped western blot of IGF-1 rb expression levels in SK-MEL-2 and HEK293 cells.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-61951-fig3-figsupp1-data2-v2.pdf"/></supplementary-material> </p><p> <supplementary-material id="fig3s1sdata3"><label>Figure 3—figure supplement 1—source data 3.</label><caption><title>Quantification of αSyn PM localization after insulin stimulation.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-61951-fig3-figsupp1-data3-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-fig3-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our results establish that clusters of endogenous αSyn are found at the PM of human A2780, HeLa, SK-MEL-2 and SH-SY5Y cells, where their abundance correlates with PIP<sub>2</sub> levels (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Specifically, we show that targeted overexpression of the PIP<sub>2</sub>-generating kinase PIPKIγ increases αSyn at the PM (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), whereas the PIP<sub>2</sub>-specific phosphatase INPP5E reduces the amount of PM αSyn (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We further demonstrate that PIP<sub>3</sub>-dependent histamine and insulin signaling redistributes αSyn to the PM (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), which collectively suggests that changes in PM PIP<sub>2</sub> and PIP<sub>3</sub> levels affect intracellular αSyn localization in a dynamic and reversible manner. Aiming for a stringent analysis, we investigated αSyn-PM interactions at strictly native, endogenous protein levels and intentionally refrained from transient or stable overexpression to not confound our analysis with non-physiological off-target effects. Moreover, we chose to study αSyn in an unaltered sequence context, that is, without modifying the protein with fluorescent dyes or fusion moieties. These requirements precluded live-cell imaging experiments to determine PM-localization kinetics, although histamine and insulin stimulation experiments suggest that endogenous αSyn pools redistribute readily. While we cannot rule out that additional secondary protein–protein interactions contribute to PM targeting, we demonstrate that αSyn directly interacts with reconstituted PIP<sub>2</sub> vesicles in vitro (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Importantly, the biophysical characteristics of these interactions are indistinguishable from other previously identified, negatively charged membrane systems with primary contacts by N-terminal αSyn residues 1–10 and progressively weaker interactions along residues 11–100. The last 40, C-terminal residues of αSyn are not involved in PIP<sub>2</sub> membrane binding, similar to all other reconstituted vesicular or planar lipid surface interactions studied thus far (<xref ref-type="bibr" rid="bib10">Bodner et al., 2009</xref>; <xref ref-type="bibr" rid="bib22">Fusco et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Perrin et al., 2000</xref>). Based on the known preferences for negatively charged phospholipids, PIP<sub>2</sub> and PIP<sub>3</sub> constitute intuitive αSyn binding partners. Not only because of their highly acidic nature (<xref ref-type="bibr" rid="bib40">Kooijman et al., 2009</xref>), but also because of their acyl chain compositions containing saturated stearic-(18:0) and polyunsaturated arachidonic acids (20:4), the latter conferring ‘shallow’ lipid packing defects (<xref ref-type="bibr" rid="bib6">Bigay and Antonny, 2012</xref>) that are ideally suited to accommodate αSyn’s helical conformation(s) (<xref ref-type="bibr" rid="bib62">Pranke et al., 2011</xref>; <xref ref-type="bibr" rid="bib60">Pinot et al., 2014</xref>). Thus, from a biophysical point of view, phosphatidylinositol polyphosphates satisfy many of the known requirements for efficient αSyn membrane binding. From a biological point of view, PIPs are ubiquitously expressed and stringently required for exocytosis and endocytosis, especially in neurons, where highly abundant PIP<sub>2</sub> and PIP<sub>3</sub>pools (up to ~6 mol%) mark SV uptake and release sites (<xref ref-type="bibr" rid="bib34">James et al., 2008</xref>). Multiple PIP-binding proteins mediate key steps in SV transmission and recycling (<xref ref-type="bibr" rid="bib15">Di Paolo et al., 2004</xref>; <xref ref-type="bibr" rid="bib53">Milosevic et al., 2005</xref>) and, although, αSyn has been implicated in synaptic exocytosis and endocytosis, its role(s) in these processes is ill defined (<xref ref-type="bibr" rid="bib32">Huang et al., 2019</xref>).</p><p>A2780, HeLa, SH-SY5Y and SK-MEL-2 cells are poor surrogates for primary neurons and discussing our results in relation to possible scenarios at the synapse is futile. Endogenous levels of αSyn in the tested cell lines are low, particularly in comparison to presynaptic boutons, where αSyn concentrations reach up to 50 μM (<xref ref-type="bibr" rid="bib78">Wilhelm et al., 2014</xref>). Similarly, the abundance of PIP<sub>2</sub> and PIP<sub>3</sub> is much smaller than at presynaptic terminals (<xref ref-type="bibr" rid="bib34">James et al., 2008</xref>). Hence, αSyn-PIP scenarios in the tested cell lines and in synaptic boutons are at opposite ends of protein and lipid concentration scales. Nonetheless, we believe that key conclusions of our study are generally valid, especially because correlated localizations are equally prominent in non-neuronal cells. The affinity of αSyn to PIP<sub>2 </sub>vesicles has been reported to be in the low μM range (<xref ref-type="bibr" rid="bib56">Narayanan and Scarlata, 2001</xref>), similar to most other reconstituted membrane systems containing negatively charged phospholipids (<xref ref-type="bibr" rid="bib52">Middleton and Rhoades, 2010</xref>; <xref ref-type="bibr" rid="bib55">Narayanan et al., 2005</xref>; <xref ref-type="bibr" rid="bib10">Bodner et al., 2009</xref>; <xref ref-type="bibr" rid="bib17">Dikiy and Eliezer, 2014</xref>; <xref ref-type="bibr" rid="bib22">Fusco et al., 2014</xref>). In comparison, average dissociation constants for canonical PIP-binding scaffolds such as PH, C2, FYVE, and ENTH domains vary between μM and mM (<xref ref-type="bibr" rid="bib2">Balla, 2005</xref>; <xref ref-type="bibr" rid="bib50">McLaughlin et al., 2002</xref>). By contrast, disordered polybasic PIP-binding motifs target negatively charged membranes with much weaker affinities and in a non-discriminatory fashion based on complementary electrostatic interactions (<xref ref-type="bibr" rid="bib51">McLaughlin and Murray, 2005</xref>). αSyn-PIP binding may define a third class of interactions that is comparable in strength to folded protein domains, but driven, to large parts, by electrostatic contacts similar to those of polybasic motifs (<xref ref-type="bibr" rid="bib26">Galvagnion, 2017</xref>). Based on these affinity considerations, we speculate that αSyn may successfully compete for cellular PIP<sub>2</sub>-PIP<sub>3</sub> binding sites with other proteins, particularly when their abundance is in a comparable range. For binding scenarios at presynaptic terminals, this is likely the case.</p><p>Our findings are additionally supported by recent data showing that intracellular αSyn concentrations directly influenced cellular PIP<sub>2</sub> levels and that protein reduction diminished PIP<sub>2</sub> abundance, whereas αSyn overexpression increased PIP<sub>2</sub> synthesis and produced significantly elongated axons in primary cortical neurons (<xref ref-type="bibr" rid="bib67">Schechter et al., 2020a</xref>). Conspicuously, these effects depended on αSyn’s ability to interact with membranes and were absent in a membrane-binding-deficient mutant (i.e., K10E-K12E) (<xref ref-type="bibr" rid="bib67">Schechter et al., 2020a</xref>). Because PM expansions require dedicated cycles of endocytosis and exocytosis (<xref ref-type="bibr" rid="bib59">Pfenninger, 2009</xref>), αSyn-PIP interactions may contribute to both types of processes, as has been suggested earlier (<xref ref-type="bibr" rid="bib44">Lautenschläger et al., 2017</xref>). PM-specific αSyn-lipid interactions were additionally confirmed by ‘unroofing’ experiments in related SK-MEL-28 cells (<xref ref-type="bibr" rid="bib38">Kaur and Lee, 2020</xref>), where endogenous protein pools colocalized with members of the exocytosis machinery including the known αSyn binding partners Rab3A (<xref ref-type="bibr" rid="bib12">Chen et al., 2013</xref>) and synaptobrevin-2/VAMP2 (<xref ref-type="bibr" rid="bib11">Burré et al., 2010</xref>). Two other studies implicated αSyn and αSyn-PIP<sub>2</sub> interactions in clathrin assembly and clathrin-mediated endocytosis, respectively (<xref ref-type="bibr" rid="bib74">Vargas et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Schechter et al., 2020b</xref>), which further strengthens the notion that phosphatidylinositol polyphosphates contribute to αSyn functions at the PM.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Cell line (<italic>Homo sapiens</italic>)</td><td>A2780</td><td>Sigma-Aldrich</td><td>Cat# 93112519 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0134">CVCL_0134</ext-link></td><td/></tr><tr><td>Cell line (<italic>Homo sapiens</italic>)</td><td>HeLa</td><td>Sigma-Aldrich</td><td>Cat# 93021013 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0030">CVCL_0030</ext-link></td><td/></tr><tr><td>Cell line (<italic>Homo sapiens</italic>)</td><td>SH-SY5Y</td><td>Sigma-Aldrich</td><td>Cat# 94030304 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0019">CVCL_0019</ext-link></td><td/></tr><tr><td>Cell line (<italic>Homo sapiens</italic>)</td><td>SK-MEL-2</td><td>Dr. Ronit Sharon <break/>(Hebrew University, Israel) <xref ref-type="bibr" rid="bib67">Schechter et al., 2020a</xref></td><td/><td/></tr><tr><td>Strain, strain background (<italic>Escherichia coli</italic>)</td><td>BL21 (DE3) Star</td><td>Thermo Fisher Scientific</td><td>Cat# C601003</td><td>Chemically Competent Cells</td></tr><tr><td>Antibody</td><td>Anti-αSyn <break/>(mouse monoclonal)</td><td>Santa Cruz</td><td>Cat# sc69977 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1118910">AB_1118910</ext-link></td><td>IF (1:200) <break/>WB (1:100)</td></tr><tr><td>Antibody</td><td>Anti-αSyn MJFR1 <break/>(rabbit monoclonal)</td><td>Abcam</td><td>Cat# ab138501 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2537217">AB_2537217</ext-link></td><td>WB (1:10,000)</td></tr><tr><td>Antibody</td><td>Anti-PI(4,5)P<sub>2</sub> <break/>(mouse monoclonal)</td><td>Echelon Biosciences</td><td>Cat# Z-P045 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_427225">AB_427225</ext-link></td><td>IF (1:100)</td></tr><tr><td>Antibody</td><td>Anti-VAMP2 <break/>(rabbit monoclonal)</td><td>Cell Signalling</td><td>Cat# 13508 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2798240">AB_2798240</ext-link></td><td>IF (1:200)</td></tr><tr><td>Antibody</td><td>Anti-beta actin <break/>(mouse monoclonal)</td><td>Abcam</td><td>Cat# ab6276 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2223210">AB_2223210</ext-link></td><td>WB (1:5000)</td></tr><tr><td>Antibody</td><td>Anti-IGF-I Receptor ß <break/>(D23H3) (rabbit monoclonal)</td><td>Cell Signalling</td><td>Cat # 9750 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10950969">AB_10950969</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG Alexa 647 conjugated <break/>(goat polyclonal)</td><td>Abcam</td><td>Cat# ab150119 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2811129">AB_2811129</ext-link></td><td>IF (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-rabbit IgG Alexa 555 conjugated <break/>(donkey polyclonal)</td><td>Invitrogen</td><td>Cat# A-31572 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_162543">AB_162543</ext-link></td><td>IF (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG <break/>HRP-conjugated <break/>(goat polyclonal)</td><td>Sigma-Aldrich</td><td>Cat# A9917 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_258476">AB_258476</ext-link></td><td>WB (1:10,000)</td></tr><tr><td>Antibody</td><td>Anti-rabbit IgG <break/>HRP-conjugated <break/>(goat polyclonal)</td><td>Jackson <break/>Immuno Research Laboratories</td><td>Cat# 111-035-003 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2313567">AB_2313567</ext-link></td><td>WB (1:5000)</td></tr><tr><td>Recombinant DNA reagent</td><td>EGFP-PLCδ<sub>1</sub>-PH</td><td>Dr. Volker Haucke <break/>(Leibniz Institute of Molecular Pharmacology, <break/>FMP-Berlin, Germany) <xref ref-type="bibr" rid="bib76">Várnai and Balla, 1998</xref></td><td/><td>PH domain, binds PI(4,5)P<sub>2</sub> at PM <break/></td></tr><tr><td>Recombinant DNA reagent</td><td>EGFP-tagged phosphatidylinositol 4-phosphate 5-kinase type Iγ (PIPKIγ)</td><td>Dr. Volker Haucke <break/>(Leibniz Institute of Molecular Pharmacology, <break/>FMP-Berlin, Germany) <xref ref-type="bibr" rid="bib41">Krauss et al., 2006</xref></td><td/><td>PIP kinase, creates PI(4,5)P<sub>2</sub> at PM <break/></td></tr><tr><td>Recombinant DNA reagent</td><td>EGFP-tagged <break/>PIPKIγ <break/>D316A <break/>(mutated)</td><td>This paper <xref ref-type="bibr" rid="bib41">Krauss et al., 2006</xref></td><td/><td>PIP kinase, inactive <break/></td></tr><tr><td>Recombinant DNA reagent</td><td>EGFP-tagged <break/>PIPKIγ <break/>K188A <break/>(mutated)</td><td>This paper <xref ref-type="bibr" rid="bib41">Krauss et al., 2006</xref></td><td/><td>PIP kinase, inactive <break/></td></tr><tr><td>Recombinant DNA reagent</td><td>MTM1-mCherry-CAAX</td><td>Dr. Volker Haucke <break/>(Leibniz Institute of Molecular Pharmacology, <break/>FMP-Berlin, Germany) <xref ref-type="bibr" rid="bib61">Posor et al., 2013</xref></td><td/><td>PIP phosphatase, acts on PI(3)P Targeted to PM</td></tr><tr><td>Recombinant DNA reagent</td><td>INPP5E-mCherry-CAAX</td><td>Dr. Volker Haucke <break/>(Leibniz Institute of Molecular Pharmacology, <break/>FMP-Berlin, Germany) <xref ref-type="bibr" rid="bib61">Posor et al., 2013</xref></td><td/><td>PIP phosphatase, acts on PI(4,5)P<sub>2</sub>Targeted to PM</td></tr><tr><td>Recombinant DNA reagent</td><td>PTEN-mCherry-CAAX</td><td>Dr. Volker Haucke <break/>(Leibniz Institute of Molecular Pharmacology, <break/>FMP-Berlin, Germany) <xref ref-type="bibr" rid="bib61">Posor et al., 2013</xref></td><td/><td>PIP phosphatase, acts on PI(3,4,5)P<sub>3</sub>Targeted to PM</td></tr><tr><td>Recombinant DNA reagent</td><td>INPP4A-mCherry-CAAX (mutated)</td><td>Dr. Volker Haucke <break/>(Leibniz Institute of Molecular Pharmacology, <break/>FMP-Berlin, Germany) <xref ref-type="bibr" rid="bib61">Posor et al., 2013</xref></td><td/><td>PIP phosphatase inactive <break/>Targeted to PM</td></tr><tr><td>Recombinant DNA reagent</td><td>Human histamine 1 receptor (H1R)</td><td>Dr. Ronit Sharon <break/>(Hebrew University, Israel) <xref ref-type="bibr" rid="bib42">Kumar et al., 2017</xref></td><td/><td>Human histamine 1 receptor</td></tr><tr><td>Recombinant DNA reagent</td><td>GRP1-PH pEGFP-C1</td><td>Addgene <xref ref-type="bibr" rid="bib39">Kavran et al., 1998</xref></td><td>Plasmid# 71378 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_71378">Addgene_71378</ext-link></td><td>PH domain binds PI(3,4,5)P<sub>3</sub></td></tr><tr><td>Sequence-based reagent</td><td>PIPKIγ D316A_Fw</td><td>This paper</td><td>PCR primer <break/>(forward)</td><td><named-content content-type="sequence">GTTTCAAGATCATGGCCTACAGCCTGCTGC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>PIPKIγ D316A_Rv</td><td>This paper</td><td>PCR primer <break/>(reverse)</td><td><named-content content-type="sequence">GCAGCAGGCTGTAGGCCATGATCTTGAAAC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>PIPKIγ K188A_Fw</td><td>This paper</td><td>PCR primer <break/>(forward)</td><td><named-content content-type="sequence">GTTCATCATCGCCACCGTCATGCACAAGGAGG</named-content></td></tr><tr><td>Sequence-based reagent</td><td>PIPKIγ K188A_Rv</td><td>This paper</td><td>PCR primer <break/>(reverse)</td><td><named-content content-type="sequence">TCGTCGTCGCTGGTGACG</named-content></td></tr><tr><td>Peptide, recombinant protein</td><td>N-terminally acetylated αSyn</td><td>This paper <xref ref-type="bibr" rid="bib73">Theillet et al., 2016</xref></td><td/><td>Purified from <italic>E. coli</italic> BL21 (DE3) Star</td></tr><tr><td>Peptide, recombinant protein</td><td>N-terminally truncated (ΔN) αSyn</td><td>This paper <xref ref-type="bibr" rid="bib73">Theillet et al., 2016</xref></td><td/><td>Purified from <italic>E. coli</italic> BL21 (DE3) Star</td></tr><tr><td>Peptide, recombinant protein</td><td>N-terminally acetylated αSyn (F4A-Y39A) mutated</td><td>This paper <xref ref-type="bibr" rid="bib73">Theillet et al., 2016</xref></td><td/><td>Purified from <italic>E. coli</italic> BL21 (DE3) Star</td></tr><tr><td>Commercial assay or kit</td><td>Q5 Site-Directed Mutagenesis Kit</td><td>New England BioLabs</td><td>Cat# E0554S</td><td/></tr><tr><td>Commercial assay or kit</td><td>BCA protein quantification kit</td><td>Thermo Fisher</td><td>Cat# 23227</td><td/></tr><tr><td>Commercial assay or kit</td><td>SuperSignal West Pico PLUS Chemiluminescent Substrate</td><td>Thermo Fisher</td><td>Cat# 34579</td><td/></tr><tr><td>Chemical compound, drug</td><td>All-trans retinoic acid</td><td>Sigma-Aldrich</td><td>Cat# R2625</td><td/></tr><tr><td>Chemical compound, drug</td><td>Recombinant human/murine/rat BDNF</td><td>Peprotech</td><td>Cat# 450-02</td><td/></tr><tr><td>Software, algorithm</td><td>Image Analysis <break/>FIJI</td><td><ext-link ext-link-type="uri" xlink:href="http://imagej.net/Fiji">imagej.net/Fiji</ext-link> <xref ref-type="bibr" rid="bib69">Schindelin et al., 2012</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>Multi-dimensional NMR data processing PROSA</td><td>Dr. Peter Güntert <break/>Goethe-University Frankfurt am Main, Germany <break/><xref ref-type="bibr" rid="bib30">Güntert et al., 1992</xref> <break/></td><td/><td/></tr><tr><td>Software, algorithm</td><td>Computer-aided NMR resonance assignment CARA</td><td>cara.nmr.ch</td><td/><td>PhD thesis Rochus Keller <break/>ETH Nr. 15947</td></tr><tr><td>Others</td><td>Lipofectamine 3000</td><td>Thermo Fisher Scientific</td><td>Cat# L3000015</td><td/></tr><tr><td>Others</td><td>TransIT-X2</td><td>Mirus Bio</td><td>Cat# MIR 6000</td><td/></tr><tr><td>Others</td><td>DOPC</td><td>Avanti Polar Lipids</td><td>Cat# 850375</td><td/></tr><tr><td>Others</td><td>Brain PI(4,5)P<sub>2</sub></td><td>Avanti Polar Lipids</td><td>Cat# 840046</td><td/></tr><tr><td>Others</td><td>IP<sub>6</sub></td><td>Dr. Dorothea Fiedler <break/>(Leibniz Institute of Molecular Pharmacology, <break/>FMP-Berlin, Germany)</td><td/><td>In-house synthesis</td></tr><tr><td>Others</td><td>PLC from <italic>Clostridium perfringens</italic> (<italic>Clostridium welchii</italic>)</td><td>Sigma-Aldrich</td><td>Cat# 9001-86-9</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mammalian cell lines and growth media</title><p>All cells lines used in this study are described in the Key resources table. Cells were grown in humidified 5% (v/v) CO<sub>2</sub> incubators at 37 °C in the following media supplemented with 10% (v/v) fetal bovine serum: RPMI 1640 (A2780), low glucose Dulbecco's modified eagle medium (DMEM)(HeLa), DMEM-Ham’s F-12 (SH-SY5Y), and minimum essential medium (MEM) with 1% non-essential amino acids and 2 mM glutamine (SK-MEL-2). Cells were split at 70–80% confluence with a passage number below 20 for all experiments. All cell lines were routinely tested for being mycoplasma free.</p></sec><sec id="s4-2"><title>Transient cell transfections</title><p>A2780 cells were seeded on fibronectin (Sigma-Aldrich, USA) coated 18 mm cover slips in 12-well plates at a density of 3 × 10<sup>5</sup> cells. Cells were transfected using Lipofectamine 3000 (Thermo Fisher, USA) according to the manufacturer's instructions. Undifferentiated SH-SY5Y and SK-MEL-2 cells were seeded on 18 mm coverslips at a density of 2 × 10<sup>5</sup> cells and transfected using TransIT-X2 (Mirus Bio, USA) according to the manufacturer's instructions. Details of transfection plasmids and mutagenesis primers are provided in the Key Resources Table. Kinase-inactive PIPKIγ mutants were generated with the Q5 site-directed mutagenesis kit (New England BioLabs, USA). Mutant PIPKIγ was confirmed by DNA sequencing. 1 μg of plasmids was used in all cases. Following transfection, cells were grown for 24 hr before analysis.</p></sec><sec id="s4-3"><title>siRNA knockdown experiments</title><p>Commercial siRNA mixtures against human αSyn (Dharmacon, USA, ON-TARGET plus human SNCA, cat.# L-002000-00-0005) and a non-targeted control (cat.# D-001810-10-05) were used. A2780 cells were seeded at a density of 6 × 10<sup>5</sup> cells and transfected with 1.7 μg of the respective siRNA mixtures using Lipofectamine 3000 according to the manufacturer’s instructions. After transfection, cells were grown for 48 hr before analysis.</p></sec><sec id="s4-4"><title>SH-SY5Y differentiation</title><p>Stringent SH-SY5Y differentiation was performed according to <xref ref-type="bibr" rid="bib20">Encinas et al., 2000</xref>. In short, cells were seeded at a density of 2 × 10<sup>5</sup> in collagen-coated six-well plates. Twenty-four hours after seeding, cells were pre-differentiated with 10 μM of all trans RA in growth medium for 5 days. Subsequently, cells were cultured in serum-free medium supplemented with 50 ng/mL BDNF (Peprotech, Israel) for 7 days to obtain terminal neuronal differentiation. During the entire process, growth media were exchanged every 2–3 days.</p></sec><sec id="s4-5"><title>Immunofluorescence</title><p>For IF imaging of endogenous αSyn and expressed PIP-kinase/phosphatases, cells were washed 3 × 5 min with PBS and fixed in 4% (w/v) paraformaldehyde (PFA) for 15 min at room temperature (RT). For PM staining with 5 μg/mL Alexa Fluor 350/tetramethylrhodamine conjugated to wheat germ agglutinin (WGA) (Invitrogen, USA), cells were fixed and washed with PBS before application for 10 min at RT. Excess dye was washed off with PBS. For antibody staining, cells were permeabilized with 0.5% saponin in PBS for 10 min and blocked with 5% (w/v) bovine serum albumin (Sigma-Aldrich, USA) in PBS for 30 min. After blocking, cells were incubated with anti-αSyn antibody for 90 min at RT. After washing 3 × 5 min with PBS, cover slips were incubated with Alexa Fluor-tagged secondary antibody for 45 min at RT. Before confocal microscopy, cover slips were mounted with Immu-Mount (Thermo Fisher, USA), after 3 × 5 min PBS washes. IF detection of PI(4,5)P<sub>2</sub> at the PM was performed according to <xref ref-type="bibr" rid="bib31">Hammond et al., 2009</xref>) with slight modifications. A2780 and SK-MEL-2 cells were cultured on fibronectin-coated coverslips and pre-extracted in PHEM buffer (60 mM PIPES (piperazine-N,N′-bis(2-ethanesulfonic acid), 25 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 5 mM EGTA (ethylene glycol-bis(β-aminoethyl ether)-<italic>N</italic>,<italic>N</italic>,<italic>N</italic>′,<italic>N</italic>′-tetraacetic acid), 1 mM MgCl<sub>2</sub>) to remove the majority of soluble cytoplasmic proteins. Cells were fixed with 4% PFA and 0.2% glutaraldehyde in PHEM buffer for 15 min at RT. All post-fixation steps until mounting were carried out at 4 °C. Washes were performed with ice-cold PIPES buffer (20 mM PIPES, pH 6.8, 137 mM NaCl, 2.7 mM KCl) to minimize damage to endogenous PIP moieties. Following fixation, cells were washed thrice in PIPES buffer containing 50 mM NH<sub>4</sub>Cl and subsequently blocked and permeabilized in PIPES buffer supplemented with 5% ‘normal goat serum’ and 0.5% saponin for 30 min. Post blocking, cells were incubated with anti-PI(4,5)P<sub>2</sub> and anti-αSyn antibodies for 60 min, washed thrice, and incubated with Alexa Fluor 647 secondary antibody for 45 min. Before confocal microscopy, cover slips were mounted with Immu-Mount (Thermo Fisher, USA) after 3 × 5 min PIPES buffer washes. All primary and secondary antibody details are provided in the Key Resources Table.</p></sec><sec id="s4-6"><title>Confocal microscopy</title><p>Confocal microscopy imaging was performed on a Nikon spinning disk confocal microscope with an oil ×60 objective and additional ×1.5 magnification. Four channels in five optical sections from the basal PM plane were acquired with excitation wavelengths of 405 (blue, 50% laser power, for WGA), 488 (green, 20% for GFP), 568 (red, 20% for mCherry), and 647 (far-red, 20% for goat anti-mouse) with 200 ms exposure times. At least 25 images per biological replicate were collected and 3–4 replicates per experiment were analyzed.</p></sec><sec id="s4-7"><title>TIRF microscopy</title><p>For TIRF localization of endogenous αSyn at the PM, A2780, HeLa, SH-SY5Y, and SK-MEL-2 cells were cultured on 18 mm fibronectin-coated coverslips at a density of 2 × 10<sup>5</sup> cells for 24 hr and fixed with 4% PFA. After fixation, antibody detection was performed as described in the previous section. Coverslips for TIRF imaging were mounted in PBS after immunostaining and imaged on an Andor Dragonfly spinning disk microscope with a TIRF 100×/NA 1.45 oil objective. For TIRF detection of PM-proximal fluorescence signals, evanescent fields were kept at 50 nm in all experiments. Four lasers operating at 405 nm (15% laser power), 488 nm (20% laser power), 561 nm (20% laser power), and 647 nm (20% laser power) were used for fluorophore excitation along with 200 ms exposure time for image acquisition. At least 20 images per biological replicate were collected and three replicates per experiment were analyzed.</p></sec><sec id="s4-8"><title>Histamine and insulin stimulation</title><p>PI-3 kinase activity was stimulated by either insulin or histamine addition. For insulin stimulation via the endogenously expressed insulin-like growth factor-1 receptor β (IGF-1 Rβ) (<xref ref-type="bibr" rid="bib18">Dricu et al., 1999</xref>), SK-MEL-2 cells were seeded on coverslips and starved in Hank's balanced salt solution (HBSS) for 18 hr, as described (<xref ref-type="bibr" rid="bib28">Gray et al., 1999</xref>). 100 nM of insulin was added for 10 min and cells were fixed immediately afterwards. For histamine stimulation, SK-MEL-2 cells were seeded on 18 mm coverslips at a density of 2 × 10<sup>5</sup>, transiently transfected with histamine 1 receptor (H1R) and serum-starved for 3 hr, as described in <xref ref-type="bibr" rid="bib54">Mizuguchi et al., 2011</xref>. 500 μM of histamine was added and cells were fixed at indicated time points. All cell samples were further processed as previously outlined for TIRF procedures. F-Actin was detected by Phalloidin-Alexa Fluor 405 staining (1:400, Invitrogen, USA) during secondary antibody incubation.</p></sec><sec id="s4-9"><title>Image analysis and quantification</title><p>Image analysis and quantification were performed in Fiji (<xref ref-type="bibr" rid="bib69">Schindelin et al., 2012</xref>). For confocal image quantification, focal planes of apical and basal PMs were selected manually. Images were segmented based on GFP signals by automatic thresholding according to <xref ref-type="bibr" rid="bib33">Huang and Wang, 1995</xref>. Threshold regions were marked as regions of interest (ROIs), copied to the far-red channel (αSyn IF), and fluorescence intensities were determined. In the box plots of <xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref> and <xref ref-type="fig" rid="fig3">Figure 3A, B</xref>, each ROI corresponds to a single cell and is represented as a data point. For TIRF data in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, D</xref>, images were segmented based on Phalloidin signals via automated thresholding using the default algorithm in Fiji (<xref ref-type="bibr" rid="bib79">Zonderland et al., 2019</xref>). Different than for confocal images in <xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig3">3</xref>, TIRF ROIs consist of multiple adjacent cells in a single frame that were copied to the far-red channel (αSyn IF). ROIs of less than 2 μm<sup>2</sup> in size were excluded. The Fiji particle counting routine was used to determine the number of αSyn puncta in each ROI. The number of cells in each image was determined manually based on cell outlines marked by Phalloidin. In <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, D</xref>, data points in box plots were calculated by dividing the number of αSyn puncta per image by the cell count. All box plots depict median values (center lines) with box dimensions representing the 25th and 75th percentiles. Whiskers extend to 1.5 times the interquartile range and depict the 5th and 95th percentiles. Each box plot in <xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref> and <xref ref-type="fig" rid="fig3">Figure 3A</xref> corresponds to 110–120 data points combined from four independent biological replicates. Box plots in <xref ref-type="fig" rid="fig3">Figure 3B</xref> contain data points collected per cell (n ~ 80) from a single experiment but representative of three independent experiments with similar results. Box plots in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, D</xref> contain data points from ~120 cells, combined from three independent biological replicates.</p></sec><sec id="s4-10"><title>Statistical analysis</title><p>For box plots, data points considered ‘outliers’ were determined based on the criteria defined in the <xref ref-type="bibr" rid="bib29">Grubbs, 1969</xref> outlier test and omitted. Analysis of variance tests with Bonferroni’s post-tests (<xref ref-type="bibr" rid="bib1">Armstrong, 2014</xref>; <xref ref-type="bibr" rid="bib19">Dunn, 1961</xref>) were used to determine the statistical significance of experiments with more than two samples, whereas Student’s <italic>t</italic> tests were performed to assess statistical differences between samples (<xref ref-type="bibr" rid="bib37">Kalpić et al., 2011</xref>). Significance is given as NS &gt;0.05; ∗p&lt;0.05; ∗∗p&lt;0.01; ∗∗∗p&lt;0.001. Absolute p values are given in the respective Source data files.</p></sec><sec id="s4-11"><title>Cell lysate preparation</title><p>Lysates of A2780, HeLa, SH-SY5Y, and SK-MEL-2 cell lines were prepared by detaching ~5–10 million cells with trypsin/EDTA (0.05%/0.02%) and harvested by centrifugation at 130 × <italic>g</italic> for 5 min at 25 °C. Sedimented cells were washed once with PBS, counted on a haemo-cytometer, and pelleted again by centrifugation. After resuspending cells in PBS with proteinase inhibitor cocktail (Roche, Switzerland), yielding a cell count of 2 × 10<sup>7</sup> cells/mL, they were lysed by repeated freeze–thaw cycles. Lysates were cleared by centrifugation at 16,000 × <italic>g</italic> for 30 min. Supernatants were removed, and total protein concentration was measured with a bicinchoninic acid (BCA) assay kit (Thermo Fisher, USA). For western blotting, 25 µg of protein (per lane, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) or 50 µg of protein (per lane, all other figures) were applied onto SDS-PAGE.</p></sec><sec id="s4-12"><title>Western blotting</title><p>Cell lysates and recombinant protein samples were boiled in Laemmli buffer for 10 min before SDS-PAGE separation on commercial, precast 4–18% gradient gels (BioRad, USA). Recombinant N-terminally acetylated α-, β-, and γ-Syn were loaded as reference inputs at specified concentrations (see 'Recombinant protein expression and purification'). Proteins were transferred onto polyvinylidene fluoride (PVDF) membranes and fixed with 4% (w/v) PFA in phosphate-buffered saline (PBS) for 1 hr (<xref ref-type="bibr" rid="bib45">Lee and Kamitani, 2011</xref>). Membranes were washed 2× with PBS, 2× with tris-buffered saline with 0.1% tween 20 (TBST), and blocked in 5% milk-TBST for 1 hr. After blocking, blots were incubated with primary antibodies overnight at 4 °C. Membranes were washed and probed with horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 hr. All antibody details including respective dilutions are provided in the Key Resource Table. Membranes were developed using the SuperSignal West Pico Plus reagent (Thermo Fisher, USA), and luminescence signals were detected on a BioRad Molecular Imager.</p></sec><sec id="s4-13"><title>Western blot quantification</title><p>Intensities of αSyn and β-actin bands were quantified using the ImageLab software (BioRad, USA). αSyn reference input was used to generate a standard curve. For cell lysate samples, αSyn intensity was normalized according to the β-actin signal and cell lysate concentrations were calculated with respect to αSyn standards. Error bars denote background (noise).</p></sec><sec id="s4-14"><title>Recombinant protein expression and purification</title><p><sup>15</sup>N isotope-labeled, N-terminally acetylated, human αSyn was produced by co-expressing PT7-7 plasmids with yeast N-acetyltransferase complex B (NatB) (<xref ref-type="bibr" rid="bib36">Johnson et al., 2010</xref>) in <italic>Escherichia coli</italic> BL21 Star (DE3) cells in M9 minimal medium supplemented with 0.5 g/L of <sup>15</sup>NH<sub>4</sub>Cl (Sigma-Aldrich, USA). Unlabeled α-, β- and γ-Syn were produced in Luria-Bertani (LB) medium. Generation of αSyn mutants ΔN and F4A-Y39A was described previously (<xref ref-type="bibr" rid="bib73">Theillet et al., 2016</xref>). For recombinant protein purification under non-denaturing conditions, we followed the protocol by <xref ref-type="bibr" rid="bib73">Theillet et al., 2016</xref>. Purification of αSyn F4A-Y39A was identical to wild-type αSyn. Lacking the N-terminal substrate specificity for NatB, αSyn ΔN was produced in its non-acetylated form and purified as the wild-type protein. Methionine-oxidized <sup>15</sup>N isotope-labeled wild-type αSyn was expressed and purified as described (<xref ref-type="bibr" rid="bib9">Binolfi et al., 2016</xref>). Protein samples were concentrated to 1–1.2 mM in NMR buffer (25 mM sodium phosphate, 150 mM NaCl) at pH 7.0. Protein concentrations were determined spectrophotometrically by UV absorbance measurements at 280 nm with ε = 5960 M<sup>−1 </sup>cm<sup>−1</sup> for α-, β-Syn ΔN, and methionine-oxidized αSyn. For αSyn F4A-Y39A and γ-Syn, ε = 4470 and 1490 M<sup>−1 </sup>cm<sup>−1</sup> were used. Final aliquots of protein stock solutions were snap frozen in liquid nitrogen and stored at −80 °C until use.</p></sec><sec id="s4-15"><title>Reconstituted PI(4,5)P<sub>2</sub> vesicles</title><p>Phospholipids were purchased from Avanti Polar Lipids (USA). Large unilamellar vesicles (LUVs, 100 nm) were prepared from 100% brain (porcine) PIP<sub>2</sub>. A thin lipid film was formed in a glass vial by gently drying 1 mg of PIP<sub>2</sub> in chloroform-methanol under a stream of nitrogen. To remove residual traces of organic solvent, the lipid film was placed under vacuum overnight. 0.5 mL NMR buffer was then added to hydrate the lipid film for 1 hr at RT while agitating. After five freeze–thaw cycles on dry ice and incubation in a water bath at RT, the lipid suspension was sonicated at 4 °C for 20 min at 30% power settings (Bandelin, Germany). Resulting PIP<sub>2</sub> LUVs (2 mg/mL) were used immediately. αSyn:PIP<sub>2</sub> molar ratios for sample preparations were calculated using a PIP<sub>2</sub> lipid mass of 1096 Da. For PIP<sub>2</sub> titration experiments, 1-, 5-, 10-, 15-, 20-, and 30-fold molar excess of lipids was added to 60 μM of <sup>15</sup>N isotope-labeled, N-terminally acetylated αSyn (total volume 120 μL) and αSyn PIP<sub>2</sub> samples were incubated for 45 min at RT before NMR and CD measurements. Following the same procedure, mixed PC-PIP<sub>2</sub> (PC:PIP<sub>2</sub> mass ratio 9:1) suspensions were prepared using 9 mg of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC, 786 Da) and 1 mg PIP<sub>2</sub>. The dried lipid film was hydrated with 0.25 mL NMR buffer. The PC-PIP<sub>2</sub> suspension was then extruded through polycarbonate membranes with a pore size of 100 nm according to the manufacturer’s instructions (mini-extruder, Avanti Polar Lipids) and resulting PC-PIP<sub>2</sub> LUVs (40 mg/mL, PC:PIP<sub>2</sub> molar ratio 13:1) were used immediately. For sample preparations, an approximate PC-PIP<sub>2</sub> lipid mass of ~810 Da ((13/14) × 786 Da + (1/14) × 1096 Da) was used to calculate the αSyn:PC-PIP<sub>2</sub> molar ratios. <sup>15</sup>N isotope-labeled, N-terminally acetylated αSyn (60 μM) was incubated with ~80-, ~170-, ~340-, and ~680-fold molar excess of total PC-PIP<sub>2</sub> lipids. αSyn PC-PIP<sub>2</sub> samples (total volume 120 μL) were incubated for 45 min at RT before CD, NMR, and DLS experiments. Synthetic inositol hexaphosphate (IP<sub>6</sub>) was kindly provided by Dr. Dorothea Fiedler, Department of Chemical Biology, Leibniz Institute of Molecular Pharmacology (FMP-Berlin). Before NMR measurements, 50 μM αSyn was incubated with 200 μM IP<sub>6</sub> in NMR buffer (total volume 120 μL) for 45 min at RT.</p></sec><sec id="s4-16"><title>Phospholipase C reaction</title><p>PLC was purchased from Sigma-Aldrich (USA) and the lyophilized powder was dissolved in NMR buffer at 1000 units (U)/mL. αSyn PC-PIP<sub>2</sub> samples at ~680-fold molar excess of PC-PIP<sub>2</sub> lipids (60 μM αSyn, ~40 mM PC-PIP<sub>2</sub>) were incubated while agitating at 37 °C for 45 min with 10 U of PLC and 1 mM phenylmethylsulfonyl fluoride (PMSF) in a total volume of 120 μL.</p></sec><sec id="s4-17"><title>NMR spectroscopy</title><p>For best comparison of protein reference and αSyn-lipid NMR data, final concentrations of <sup>15</sup>N isotope-labeled, N-terminally acetylated αSyn samples were adjusted to 60 μM, supplemented with 5% D<sub>2</sub>O, and measured in 3 mm (diameter) Shigemi tubes in all cases. NMR experiments were acquired on a Bruker 600 MHz Avance spectrometer equipped with a cryogenically cooled proton-optimized <sup>1</sup>H{<sup>13</sup>C/<sup>15</sup>N} TCI probe. Reference and αSyn-lipid NMR spectra were acquired with identical spectrometer settings and general acquisition parameters. Specifically, we employed 2D <sup>1</sup>H-<sup>15</sup>N SOFAST HMQC NMR pulse sequences (<xref ref-type="bibr" rid="bib66">Schanda et al., 2005</xref>) with 512 x 128 complex points for a sweep width of 28.0 ppm (<sup>15</sup>N) and 16.7 ppm (<sup>1</sup>H), 128 scans, 60 ms recycling delay at 283 K. Inspection of the highly pH-sensitive His50 (H50) <sup>1</sup>H-<sup>15</sup>N chemical shift indicated that the sample pH changed from 7 to 6.5 during the PLC reaction (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). To accurately delineate I/I<sub>0</sub> values, we recorded reference NMR spectra at pH 6.5. All NMR spectra were processed with PROSA, zero-filled to four times the number of real points and processed without window function. Visualization and data analysis were carried out in CARA. NMR signal intensity ratios (I/I<sub>0</sub>) of isolated αSyn (I<sub>0</sub>) and in the presence of lipids (I) were determined for each residue by extracting maximal signal peak heights in the respective 2D <sup>1</sup>H-<sup>15</sup>N NMR spectra.</p></sec><sec id="s4-18"><title>CD spectroscopy</title><p>NMR samples of isolated αSyn and αSyn in the presence of lipid vesicles were diluted with NMR buffer to a final protein concentration of 10 μM for CD measurements. CD spectra (200–250 nm) were collected on a Jasco J-720 CD spectropolarimeter in a 1 mm quartz cell at 25 °C. One replicate per sample was recorded. Six scans were averaged and blank samples (without αSyn) were subtracted from protein spectra to calculate the mean residue weight ellipticity (θ<sub>MRW</sub>).</p></sec><sec id="s4-19"><title>Dynamic light scattering</title><p>DLS measurements were acquired on a Zetasizer Nano ZS (Malvern Instruments, UK) operating at a laser wavelength of 633 nm equipped with a Peltier temperature controller set to 25 °C. Data were collected on all NMR samples containing αSyn, isolated PC-PIP<sub>2</sub> vesicles and PC-PIP<sub>2</sub> vesicles in the presence of Ca<sup>2+</sup> and PLC. Using the Malvern DTS software, mean hydrodynamic diameters were calculated from three replicates of the same sample in the intensity-weighted mode.</p></sec><sec id="s4-20"><title>Negative-stain electron microscopy</title><p>NMR samples of αSyn at ~30- and ~680-fold molar excess of PIP<sub>2</sub> and PC-PIP<sub>2</sub> lipids were diluted to a protein concentration of ~10 μM in NMR buffer. 5 μL aliquots were added to glow-discharged carbon-coated copper grids for 1 min. Excess liquid was removed with filter paper and grids were washed twice with H<sub>2</sub>O before staining with 2% (w/v) uranyl acetate for 15 s. Negative-stain transmission EM images were acquired on a Technai G2 TEM.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to Dr. Peter Schmieder and Monika Beerbaum for excellent maintenance of the NMR infrastructure at the Leibniz Institute of Molecular Pharmacology (FMP Berlin) and Dr. Tali Scherf for NMR infrastructure maintenance at the Weizmann Institute of Science. We thank Dr. Dmytro Puchkov (FMP-Berlin) for assistance with negative-stain electron microscopy and Drs. Michael Krauss and Volker Haucke (FMP-Berlin) for tools and reagents, helpful discussions throughout the project and useful feedback on the manuscript. Dr. Dorothea Fiedler (FMP-Berlin) for sharing aliquots of IP<sub>6</sub>. We also thank Drs. Martin Lehmann (Cellular imaging, FMP-Berlin) and Yoseph Addadi (Life Sciences Core Facilities, Weizmann Institute of Science) for excellent maintenance of imaging facilities and their support at the respective institutes. We acknowledge the highly valuable input by Drs. Meir Schechter and Ronit Sharon, Hebrew University Jerusalem, especially with regard to time-resolved histamine experiments. We further thank them for kindly providing aliquots of the SK-MEL-2 cell line. We are grateful to Drs. Ori Avinoam, Hagen Hofmann (Weizmann), and Andres Binolfi (CONICET) for carefully reading the manuscript. CE was supported by a Swiss National Science Foundation (SNSF) Advanced -Postdoc.Mobility fellowship P300PA_160979. PS acknowledges funding by the European Research Council (ERC) Consolidator Grant NeuroInCellNMR (647474). TIRF imaging was made possible with the help and support of the de Picciotto Cancer Cell Observatory in memory of Wolfgang and Ruth Lesser. Work in the Selenko laboratory is supported by the Willner Family Foundation.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-61951-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1,2,3 and all figure supplements.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>When to use the Bonferroni correction</article-title><source>Ophthalmic and Physiological Optics</source><volume>34</volume><fpage>502</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1111/opo.12131</pub-id><pub-id pub-id-type="pmid">24697967</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balla</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions</article-title><source>Journal of Cell Science</source><volume>118</volume><fpage>2093</fpage><lpage>2104</lpage><pub-id pub-id-type="doi">10.1242/jcs.02387</pub-id><pub-id pub-id-type="pmid">15890985</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balla</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Phosphoinositides: tiny lipids with giant impact on cell regulation</article-title><source>Physiological Reviews</source><volume>93</volume><fpage>1019</fpage><lpage>1137</lpage><pub-id pub-id-type="doi">10.1152/physrev.00028.2012</pub-id><pub-id pub-id-type="pmid">23899561</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartels</surname> <given-names>T</given-names></name><name><surname>Ahlstrom</surname> <given-names>LS</given-names></name><name><surname>Leftin</surname> <given-names>A</given-names></name><name><surname>Kamp</surname> <given-names>F</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Brown</surname> <given-names>MF</given-names></name><name><surname>Beyer</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and Helix folding</article-title><source>Biophysical Journal</source><volume>99</volume><fpage>2116</fpage><lpage>2124</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2010.06.035</pub-id><pub-id pub-id-type="pmid">20923645</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname> <given-names>MJ</given-names></name><name><surname>Irvine</surname> <given-names>RF</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Inositol trisphosphate, a novel second messenger in cellular signal transduction</article-title><source>Nature</source><volume>312</volume><fpage>315</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1038/312315a0</pub-id><pub-id pub-id-type="pmid">6095092</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigay</surname> <given-names>J</given-names></name><name><surname>Antonny</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Curvature, lipid packing, and electrostatics of membrane organelles: defining cellular territories in determining specificity</article-title><source>Developmental Cell</source><volume>23</volume><fpage>886</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2012.10.009</pub-id><pub-id pub-id-type="pmid">23153485</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilanges</surname> <given-names>B</given-names></name><name><surname>Posor</surname> <given-names>Y</given-names></name><name><surname>Vanhaesebroeck</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PI3K isoforms in cell signalling and vesicle trafficking</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>20</volume><fpage>515</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0129-z</pub-id><pub-id pub-id-type="pmid">31110302</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilkova</surname> <given-names>E</given-names></name><name><surname>Pleskot</surname> <given-names>R</given-names></name><name><surname>Rissanen</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Czogalla</surname> <given-names>A</given-names></name><name><surname>Cwiklik</surname> <given-names>L</given-names></name><name><surname>Róg</surname> <given-names>T</given-names></name><name><surname>Vattulainen</surname> <given-names>I</given-names></name><name><surname>Cremer</surname> <given-names>PS</given-names></name><name><surname>Jungwirth</surname> <given-names>P</given-names></name><name><surname>Coskun</surname> <given-names>Ü</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Calcium directly regulates phosphatidylinositol 4,5-Bisphosphate headgroup conformation and recognition</article-title><source>Journal of the American Chemical Society</source><volume>139</volume><fpage>4019</fpage><lpage>4024</lpage><pub-id pub-id-type="doi">10.1021/jacs.6b11760</pub-id><pub-id pub-id-type="pmid">28177616</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binolfi</surname> <given-names>A</given-names></name><name><surname>Limatola</surname> <given-names>A</given-names></name><name><surname>Verzini</surname> <given-names>S</given-names></name><name><surname>Kosten</surname> <given-names>J</given-names></name><name><surname>Theillet</surname> <given-names>FX</given-names></name><name><surname>Rose</surname> <given-names>HM</given-names></name><name><surname>Bekei</surname> <given-names>B</given-names></name><name><surname>Stuiver</surname> <given-names>M</given-names></name><name><surname>van Rossum</surname> <given-names>M</given-names></name><name><surname>Selenko</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>10251</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10251</pub-id><pub-id pub-id-type="pmid">26807843</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodner</surname> <given-names>CR</given-names></name><name><surname>Dobson</surname> <given-names>CM</given-names></name><name><surname>Bax</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy</article-title><source>Journal of Molecular Biology</source><volume>390</volume><fpage>775</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2009.05.066</pub-id><pub-id pub-id-type="pmid">19481095</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burré</surname> <given-names>J</given-names></name><name><surname>Sharma</surname> <given-names>M</given-names></name><name><surname>Tsetsenis</surname> <given-names>T</given-names></name><name><surname>Buchman</surname> <given-names>V</given-names></name><name><surname>Etherton</surname> <given-names>MR</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro</article-title><source>Science</source><volume>329</volume><fpage>1663</fpage><lpage>1667</lpage><pub-id pub-id-type="doi">10.1126/science.1195227</pub-id><pub-id pub-id-type="pmid">20798282</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>RHC</given-names></name><name><surname>Wislet-Gendebien</surname> <given-names>S</given-names></name><name><surname>Samuel</surname> <given-names>F</given-names></name><name><surname>Visanji</surname> <given-names>NP</given-names></name><name><surname>Zhang</surname> <given-names>G</given-names></name><name><surname>Marsilio</surname> <given-names>D</given-names></name><name><surname>Langman</surname> <given-names>T</given-names></name><name><surname>Fraser</surname> <given-names>PE</given-names></name><name><surname>Tandon</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>α-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity*</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>7438</fpage><lpage>7449</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.439497</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname> <given-names>WS</given-names></name><name><surname>Jonas</surname> <given-names>A</given-names></name><name><surname>Clayton</surname> <given-names>DF</given-names></name><name><surname>George</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Stabilization of α-Synuclein secondary structure upon binding to synthetic membranes</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>9443</fpage><lpage>9449</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.16.9443</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dettmer</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rationally designed variants of α-Synuclein illuminate its in vivo Structural Properties in Health and Disease</article-title><source>Frontiers in Neuroscience</source><volume>12</volume><elocation-id>623</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2018.00623</pub-id><pub-id pub-id-type="pmid">30319334</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paolo</surname> <given-names>G</given-names></name><name><surname>Moskowitz</surname> <given-names>HS</given-names></name><name><surname>Gipson</surname> <given-names>K</given-names></name><name><surname>Wenk</surname> <given-names>MR</given-names></name><name><surname>Voronov</surname> <given-names>S</given-names></name><name><surname>Obayashi</surname> <given-names>M</given-names></name><name><surname>Flavell</surname> <given-names>R</given-names></name><name><surname>Fitzsimonds</surname> <given-names>RM</given-names></name><name><surname>Ryan</surname> <given-names>TA</given-names></name><name><surname>De Camilli</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking</article-title><source>Nature</source><volume>431</volume><fpage>415</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1038/nature02896</pub-id><pub-id pub-id-type="pmid">15386003</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paolo</surname> <given-names>G</given-names></name><name><surname>De Camilli</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Phosphoinositides in cell regulation and membrane dynamics</article-title><source>Nature</source><volume>443</volume><fpage>651</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1038/nature05185</pub-id><pub-id pub-id-type="pmid">17035995</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dikiy</surname> <given-names>I</given-names></name><name><surname>Eliezer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>N-terminal acetylation stabilizes N-terminal helicity in lipid- and Micelle-bound α-Synuclein and increases its affinity for physiological membranes</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><fpage>3652</fpage><lpage>3665</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.512459</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dricu</surname> <given-names>A</given-names></name><name><surname>Kanter</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>M</given-names></name><name><surname>Nilsson</surname> <given-names>G</given-names></name><name><surname>Hjertman</surname> <given-names>M</given-names></name><name><surname>Wejde</surname> <given-names>J</given-names></name><name><surname>Larsson</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast Cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway</article-title><source>Glycobiology</source><volume>9</volume><fpage>571</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1093/glycob/9.6.571</pub-id><pub-id pub-id-type="pmid">10336989</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="1961">1961</year><article-title>Multiple comparisons among means</article-title><source>Journal of the American Statistical Association</source><volume>56</volume><fpage>52</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1080/01621459.1961.10482090</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Encinas</surname> <given-names>M</given-names></name><name><surname>Iglesias</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Muhaisen</surname> <given-names>A</given-names></name><name><surname>Ceña</surname> <given-names>V</given-names></name><name><surname>Gallego</surname> <given-names>C</given-names></name><name><surname>Comella</surname> <given-names>JX</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells</article-title><source>Journal of Neurochemistry</source><volume>75</volume><fpage>991</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0750991.x</pub-id><pub-id pub-id-type="pmid">10936180</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortin</surname> <given-names>DL</given-names></name><name><surname>Troyer</surname> <given-names>MD</given-names></name><name><surname>Nakamura</surname> <given-names>K</given-names></name><name><surname>Kubo</surname> <given-names>S</given-names></name><name><surname>Anthony</surname> <given-names>MD</given-names></name><name><surname>Edwards</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Lipid rafts mediate the synaptic localization of alpha-synuclein</article-title><source>Journal of Neuroscience</source><volume>24</volume><fpage>6715</fpage><lpage>6723</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1594-04.2004</pub-id><pub-id pub-id-type="pmid">15282274</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname> <given-names>G</given-names></name><name><surname>De Simone</surname> <given-names>A</given-names></name><name><surname>Gopinath</surname> <given-names>T</given-names></name><name><surname>Vostrikov</surname> <given-names>V</given-names></name><name><surname>Vendruscolo</surname> <given-names>M</given-names></name><name><surname>Dobson</surname> <given-names>CM</given-names></name><name><surname>Veglia</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3827</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4827</pub-id><pub-id pub-id-type="pmid">24871041</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname> <given-names>G</given-names></name><name><surname>De Simone</surname> <given-names>A</given-names></name><name><surname>Arosio</surname> <given-names>P</given-names></name><name><surname>Vendruscolo</surname> <given-names>M</given-names></name><name><surname>Veglia</surname> <given-names>G</given-names></name><name><surname>Dobson</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural ensembles of Membrane-bound α-Synuclein reveal the molecular determinants of synaptic vesicle affinity</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>27125</elocation-id><pub-id pub-id-type="doi">10.1038/srep27125</pub-id><pub-id pub-id-type="pmid">27273030</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname> <given-names>G</given-names></name><name><surname>Chen</surname> <given-names>SW</given-names></name><name><surname>Williamson</surname> <given-names>PTF</given-names></name><name><surname>Cascella</surname> <given-names>R</given-names></name><name><surname>Perni</surname> <given-names>M</given-names></name><name><surname>Jarvis</surname> <given-names>JA</given-names></name><name><surname>Cecchi</surname> <given-names>C</given-names></name><name><surname>Vendruscolo</surname> <given-names>M</given-names></name><name><surname>Chiti</surname> <given-names>F</given-names></name><name><surname>Cremades</surname> <given-names>N</given-names></name><name><surname>Ying</surname> <given-names>L</given-names></name><name><surname>Dobson</surname> <given-names>CM</given-names></name><name><surname>De Simone</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers</article-title><source>Science</source><volume>358</volume><fpage>1440</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1126/science.aan6160</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname> <given-names>G</given-names></name><name><surname>Sanz-Hernandez</surname> <given-names>M</given-names></name><name><surname>De Simone</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Order and disorder in the physiological membrane binding of α-synuclein</article-title><source>Current Opinion in Structural Biology</source><volume>48</volume><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2017.09.004</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvagnion</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson’s Disease</article-title><source>Journal of Parkinson's Disease</source><volume>7</volume><fpage>433</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.3233/JPD-171103</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname> <given-names>M</given-names></name><name><surname>Spillantini</surname> <given-names>MG</given-names></name><name><surname>Del Tredici</surname> <given-names>K</given-names></name><name><surname>Braak</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>100 years of Lewy pathology</article-title><source>Nature Reviews Neurology</source><volume>9</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2012.242</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname> <given-names>A</given-names></name><name><surname>Van Der Kaay</surname> <given-names>J</given-names></name><name><surname>Downes</surname> <given-names>CP</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The pleckstrin homology domains of protein kinase B and GRP1 (general receptor for phosphoinositides-1) are sensitive and selective probes for the cellular detection of phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-trisphosphate in vivo</article-title><source>Biochemical Journal</source><volume>344</volume><fpage>929</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1042/bj3440929</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grubbs</surname> <given-names>FE</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>Procedures for Detecting Outlying Observations in Samples</article-title><source>Technometrics</source><volume>11</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1080/00401706.1969.10490657</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Güntert</surname> <given-names>P</given-names></name><name><surname>Dötsch</surname> <given-names>V</given-names></name><name><surname>Wider</surname> <given-names>G</given-names></name><name><surname>Wüthrich</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Processing of multi-dimensional NMR data with the new software PROSA</article-title><source>Journal of Biomolecular NMR</source><volume>2</volume><fpage>619</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1007/BF02192850</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname> <given-names>GRV</given-names></name><name><surname>Schiavo</surname> <given-names>G</given-names></name><name><surname>Irvine</surname> <given-names>RF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P2</article-title><source>Biochemical Journal</source><volume>422</volume><fpage>23</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1042/BJ20090428</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Fu</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Kang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>α-Synuclein: A Multifunctional Player in Exocytosis, Endocytosis, and Vesicle Recycling</article-title><source>Frontiers in Neuroscience</source><volume>13</volume><elocation-id>28</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2019.00028</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>L-K</given-names></name><name><surname>Wang</surname> <given-names>M-JJ</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Image thresholding by minimizing the measures of fuzziness</article-title><source>Pattern Recognition</source><volume>28</volume><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/0031-3203(94)E0043-K</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname> <given-names>DJ</given-names></name><name><surname>Khodthong</surname> <given-names>C</given-names></name><name><surname>Kowalchyk</surname> <given-names>JA</given-names></name><name><surname>Martin</surname> <given-names>TFJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Phosphatidylinositol 4,5-bisphosphate regulates SNARE-dependent membrane fusion</article-title><source>Journal of Cell Biology</source><volume>182</volume><fpage>355</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1083/jcb.200801056</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname> <given-names>E</given-names></name><name><surname>McLaurin</surname> <given-names>J</given-names></name><name><surname>Yip</surname> <given-names>CM</given-names></name><name><surname>St. George-Hyslop</surname> <given-names>P</given-names></name><name><surname>Fraser</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>α-Synuclein membrane interactions and lipid specificity</article-title><source>Journal of Biological Chemistry</source><volume>275</volume><fpage>34328</fpage><lpage>34334</lpage><pub-id pub-id-type="doi">10.1074/jbc.M004345200</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>M</given-names></name><name><surname>Coulton</surname> <given-names>AT</given-names></name><name><surname>Geeves</surname> <given-names>MA</given-names></name><name><surname>Mulvihill</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Targeted amino-terminal acetylation of recombinant proteins in <italic>E. coli</italic></article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e15801</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0015801</pub-id><pub-id pub-id-type="pmid">21203426</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kalpić</surname> <given-names>D</given-names></name><name><surname>Hlupić</surname> <given-names>N</given-names></name><name><surname>Lovrić</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><chapter-title>Student’s t-Tests</chapter-title><person-group person-group-type="editor"><name><surname>Lovric</surname> <given-names>M</given-names></name></person-group><source>International Encyclopedia of Statistical Science</source><publisher-name>Springer</publisher-name><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-04898-2</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname> <given-names>U</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Unroofing site-specific α-synuclein-lipid interactions at the plasma membrane</article-title><source>PNAS</source><volume>117</volume><fpage>18977</fpage><lpage>18983</lpage><pub-id pub-id-type="doi">10.1073/pnas.2006291117</pub-id><pub-id pub-id-type="pmid">32719116</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kavran</surname> <given-names>JM</given-names></name><name><surname>Klein</surname> <given-names>DE</given-names></name><name><surname>Lee</surname> <given-names>A</given-names></name><name><surname>Falasca</surname> <given-names>M</given-names></name><name><surname>Isakoff</surname> <given-names>SJ</given-names></name><name><surname>Skolnik</surname> <given-names>EY</given-names></name><name><surname>Lemmon</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>30497</fpage><lpage>30508</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.46.30497</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kooijman</surname> <given-names>EE</given-names></name><name><surname>King</surname> <given-names>KE</given-names></name><name><surname>Gangoda</surname> <given-names>M</given-names></name><name><surname>Gericke</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ionization properties of phosphatidylinositol polyphosphates in mixed model membranes</article-title><source>Biochemistry</source><volume>48</volume><fpage>9360</fpage><lpage>9371</lpage><pub-id pub-id-type="doi">10.1021/bi9008616</pub-id><pub-id pub-id-type="pmid">19725516</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname> <given-names>M</given-names></name><name><surname>Kukhtina</surname> <given-names>V</given-names></name><name><surname>Pechstein</surname> <given-names>A</given-names></name><name><surname>Haucke</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Stimulation of phosphatidylinositol kinase type I-mediated phosphatidylinositol (4,5)-bisphosphate synthesis by AP-2mu-cargo complexes</article-title><source>PNAS</source><volume>103</volume><fpage>11934</fpage><lpage>11939</lpage><pub-id pub-id-type="doi">10.1073/pnas.0510306103</pub-id><pub-id pub-id-type="pmid">16880396</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>R</given-names></name><name><surname>Hazan</surname> <given-names>A</given-names></name><name><surname>Geron</surname> <given-names>M</given-names></name><name><surname>Steinberg</surname> <given-names>R</given-names></name><name><surname>Livni</surname> <given-names>L</given-names></name><name><surname>Matzner</surname> <given-names>H</given-names></name><name><surname>Priel</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Activation of transient receptor potential vanilloid 1 by lipoxygenase metabolites depends on PKC phosphorylation</article-title><source>The FASEB Journal</source><volume>31</volume><fpage>1238</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1096/fj.201601132R</pub-id><pub-id pub-id-type="pmid">27986808</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunz</surname> <given-names>J</given-names></name><name><surname>Wilson</surname> <given-names>MP</given-names></name><name><surname>Kisseleva</surname> <given-names>M</given-names></name><name><surname>Hurley</surname> <given-names>JH</given-names></name><name><surname>Majerus</surname> <given-names>PW</given-names></name><name><surname>Anderson</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The activation loop of phosphatidylinositol phosphate kinases determines signaling specificity</article-title><source>Molecular Cell</source><volume>5</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(00)80398-6</pub-id><pub-id pub-id-type="pmid">10678164</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lautenschläger</surname> <given-names>J</given-names></name><name><surname>Kaminski</surname> <given-names>CF</given-names></name><name><surname>Kaminski Schierle</surname> <given-names>GS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>α-Synuclein - Regulator of exocytosis, Endocytosis, or both?</article-title><source>Trends in Cell Biology</source><volume>27</volume><fpage>468</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2017.02.002</pub-id><pub-id pub-id-type="pmid">28259601</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>BR</given-names></name><name><surname>Kamitani</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Improved immunodetection of endogenous α-synuclein</article-title><source>POS ONE</source><volume>6</volume><elocation-id>e23939</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0023939</pub-id><pub-id pub-id-type="pmid">21886844</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lokappa</surname> <given-names>SB</given-names></name><name><surname>Suk</surname> <given-names>JE</given-names></name><name><surname>Balasubramanian</surname> <given-names>A</given-names></name><name><surname>Samanta</surname> <given-names>S</given-names></name><name><surname>Situ</surname> <given-names>AJ</given-names></name><name><surname>Ulmer</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sequence and membrane determinants of the random coil-helix transition of α-synuclein</article-title><source>Journal of Molecular Biology</source><volume>426</volume><fpage>2130</fpage><lpage>2144</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2014.02.024</pub-id><pub-id pub-id-type="pmid">24607710</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahul-Mellier</surname> <given-names>AL</given-names></name><name><surname>Burtscher</surname> <given-names>J</given-names></name><name><surname>Maharjan</surname> <given-names>N</given-names></name><name><surname>Weerens</surname> <given-names>L</given-names></name><name><surname>Croisier</surname> <given-names>M</given-names></name><name><surname>Kuttler</surname> <given-names>F</given-names></name><name><surname>Leleu</surname> <given-names>M</given-names></name><name><surname>Knott</surname> <given-names>GW</given-names></name><name><surname>Lashuel</surname> <given-names>HA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The process of lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration</article-title><source>PNAS</source><volume>117</volume><fpage>4971</fpage><lpage>4982</lpage><pub-id pub-id-type="doi">10.1073/pnas.1913904117</pub-id><pub-id pub-id-type="pmid">32075919</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltsev</surname> <given-names>AS</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Levine</surname> <given-names>RL</given-names></name><name><surname>Bax</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Site-specific interaction between α-synuclein and membranes probed by NMR-observed methionine oxidation rates</article-title><source>Journal of the American Chemical Society</source><volume>135</volume><fpage>2943</fpage><lpage>2946</lpage><pub-id pub-id-type="doi">10.1021/ja312415q</pub-id><pub-id pub-id-type="pmid">23398174</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matteis</surname> <given-names>MAD</given-names></name><name><surname>Godi</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>PI-loting membrane traffic</article-title><source>Nature Cell Biology</source><volume>6</volume><fpage>487</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1038/ncb0604-487</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaughlin</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Gambhir</surname> <given-names>A</given-names></name><name><surname>Murray</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>PIP(2) and proteins: interactions, organization, and information flow</article-title><source>Annual Review of Biophysics and Biomolecular Structure</source><volume>31</volume><fpage>151</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1146/annurev.biophys.31.082901.134259</pub-id><pub-id pub-id-type="pmid">11988466</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaughlin</surname> <given-names>S</given-names></name><name><surname>Murray</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Plasma membrane phosphoinositide organization by protein electrostatics</article-title><source>Nature</source><volume>438</volume><fpage>605</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1038/nature04398</pub-id><pub-id pub-id-type="pmid">16319880</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Middleton</surname> <given-names>ER</given-names></name><name><surname>Rhoades</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Effects of curvature and composition on α-Synuclein binding to lipid vesicles</article-title><source>Biophysical Journal</source><volume>99</volume><fpage>2279</fpage><lpage>2288</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2010.07.056</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milosevic</surname> <given-names>I</given-names></name><name><surname>Sørensen</surname> <given-names>JB</given-names></name><name><surname>Lang</surname> <given-names>T</given-names></name><name><surname>Krauss</surname> <given-names>M</given-names></name><name><surname>Nagy</surname> <given-names>G</given-names></name><name><surname>Haucke</surname> <given-names>V</given-names></name><name><surname>Jahn</surname> <given-names>R</given-names></name><name><surname>Neher</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Plasmalemmal phosphatidylinositol-4,5-bisphosphate level regulates the releasable vesicle pool size in chromaffin cells</article-title><source>Journal of Neuroscience</source><volume>25</volume><fpage>2557</fpage><lpage>2565</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3761-04.2005</pub-id><pub-id pub-id-type="pmid">15758165</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuguchi</surname> <given-names>H</given-names></name><name><surname>Terao</surname> <given-names>T</given-names></name><name><surname>Kitai</surname> <given-names>M</given-names></name><name><surname>Ikeda</surname> <given-names>M</given-names></name><name><surname>Yoshimura</surname> <given-names>Y</given-names></name><name><surname>Das</surname> <given-names>AK</given-names></name><name><surname>Kitamura</surname> <given-names>Y</given-names></name><name><surname>Takeda</surname> <given-names>N</given-names></name><name><surname>Fukui</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Involvement of protein kinase Cδ/Extracellular Signal-regulated kinase/Poly(ADP-ribose) Polymerase-1 (PARP-1) Signaling pathway in Histamine-induced Up-regulation of histamine H1 receptor gene expression in HeLa cells</article-title><source>Journal of Biological Chemistry</source><volume>286</volume><fpage>30542</fpage><lpage>30551</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.253104</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narayanan</surname> <given-names>V</given-names></name><name><surname>Guo</surname> <given-names>Y</given-names></name><name><surname>Scarlata</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Fluorescence studies suggest a role for alpha-synuclein in the phosphatidylinositol lipid signaling pathway</article-title><source>Biochemistry</source><volume>44</volume><fpage>462</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1021/bi0487140</pub-id><pub-id pub-id-type="pmid">15641770</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narayanan</surname> <given-names>V</given-names></name><name><surname>Scarlata</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Membrane binding and self-association of alpha-synucleins</article-title><source>Biochemistry</source><volume>40</volume><fpage>9927</fpage><lpage>9934</lpage><pub-id pub-id-type="doi">10.1021/bi002952n</pub-id><pub-id pub-id-type="pmid">11502187</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuscher</surname> <given-names>B</given-names></name><name><surname>Kamp</surname> <given-names>F</given-names></name><name><surname>Mehnert</surname> <given-names>T</given-names></name><name><surname>Odoy</surname> <given-names>S</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Kahle</surname> <given-names>PJ</given-names></name><name><surname>Beyer</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>21966</fpage><lpage>21975</lpage><pub-id pub-id-type="doi">10.1074/jbc.M401076200</pub-id><pub-id pub-id-type="pmid">15028717</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrin</surname> <given-names>RJ</given-names></name><name><surname>Woods</surname> <given-names>WS</given-names></name><name><surname>Clayton</surname> <given-names>DF</given-names></name><name><surname>George</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>34393</fpage><lpage>34398</lpage><pub-id pub-id-type="doi">10.1074/jbc.M004851200</pub-id><pub-id pub-id-type="pmid">10952980</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfenninger</surname> <given-names>KH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Plasma membrane expansion: a neuron's Herculean task</article-title><source>Nature Reviews Neuroscience</source><volume>10</volume><fpage>251</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1038/nrn2593</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinot</surname> <given-names>M</given-names></name><name><surname>Vanni</surname> <given-names>S</given-names></name><name><surname>Pagnotta</surname> <given-names>S</given-names></name><name><surname>Lacas-Gervais</surname> <given-names>S</given-names></name><name><surname>Payet</surname> <given-names>LA</given-names></name><name><surname>Ferreira</surname> <given-names>T</given-names></name><name><surname>Gautier</surname> <given-names>R</given-names></name><name><surname>Goud</surname> <given-names>B</given-names></name><name><surname>Antonny</surname> <given-names>B</given-names></name><name><surname>Barelli</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins</article-title><source>Science</source><volume>345</volume><fpage>693</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1126/science.1255288</pub-id><pub-id pub-id-type="pmid">25104391</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posor</surname> <given-names>Y</given-names></name><name><surname>Eichhorn-Gruenig</surname> <given-names>M</given-names></name><name><surname>Puchkov</surname> <given-names>D</given-names></name><name><surname>Schöneberg</surname> <given-names>J</given-names></name><name><surname>Ullrich</surname> <given-names>A</given-names></name><name><surname>Lampe</surname> <given-names>A</given-names></name><name><surname>Müller</surname> <given-names>R</given-names></name><name><surname>Zarbakhsh</surname> <given-names>S</given-names></name><name><surname>Gulluni</surname> <given-names>F</given-names></name><name><surname>Hirsch</surname> <given-names>E</given-names></name><name><surname>Krauss</surname> <given-names>M</given-names></name><name><surname>Schultz</surname> <given-names>C</given-names></name><name><surname>Schmoranzer</surname> <given-names>J</given-names></name><name><surname>Noé</surname> <given-names>F</given-names></name><name><surname>Haucke</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate</article-title><source>Nature</source><volume>499</volume><fpage>233</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1038/nature12360</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pranke</surname> <given-names>IM</given-names></name><name><surname>Morello</surname> <given-names>V</given-names></name><name><surname>Bigay</surname> <given-names>J</given-names></name><name><surname>Gibson</surname> <given-names>K</given-names></name><name><surname>Verbavatz</surname> <given-names>J-M</given-names></name><name><surname>Antonny</surname> <given-names>B</given-names></name><name><surname>Jackson</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>α-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding</article-title><source>Journal of Cell Biology</source><volume>194</volume><fpage>89</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1083/jcb.201011118</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname> <given-names>NP</given-names></name><name><surname>Soragni</surname> <given-names>A</given-names></name><name><surname>Rabe</surname> <given-names>M</given-names></name><name><surname>Verdes</surname> <given-names>D</given-names></name><name><surname>Liverani</surname> <given-names>E</given-names></name><name><surname>Handschin</surname> <given-names>S</given-names></name><name><surname>Riek</surname> <given-names>R</given-names></name><name><surname>Seeger</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mechanism of membrane interaction and disruption by α-synuclein</article-title><source>Journal of the American Chemical Society</source><volume>133</volume><fpage>19366</fpage><lpage>19375</lpage><pub-id pub-id-type="doi">10.1021/ja2029848</pub-id><pub-id pub-id-type="pmid">21978222</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruderman</surname> <given-names>NB</given-names></name><name><surname>Kapeller</surname> <given-names>R</given-names></name><name><surname>White</surname> <given-names>MF</given-names></name><name><surname>Cantley</surname> <given-names>LC</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Activation of phosphatidylinositol 3-kinase by insulin</article-title><source>PNAS</source><volume>87</volume><fpage>1411</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.4.1411</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saheki</surname> <given-names>Y</given-names></name><name><surname>Bian</surname> <given-names>X</given-names></name><name><surname>Schauder</surname> <given-names>CM</given-names></name><name><surname>Sawaki</surname> <given-names>Y</given-names></name><name><surname>Surma</surname> <given-names>MA</given-names></name><name><surname>Klose</surname> <given-names>C</given-names></name><name><surname>Pincet</surname> <given-names>F</given-names></name><name><surname>Reinisch</surname> <given-names>KM</given-names></name><name><surname>De Camilli</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Control of plasma membrane lipid homeostasis by the extended synaptotagmins</article-title><source>Nature Cell Biology</source><volume>18</volume><fpage>504</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1038/ncb3339</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schanda</surname> <given-names>P</given-names></name><name><surname>Kupče</surname> <given-names>E</given-names></name><name><surname>Brutscher</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>SOFAST-HMQC experiments for recording two-dimensional deteronuclear correlation spectra of proteins within a few seconds</article-title><source>Journal of Biomolecular NMR</source><volume>33</volume><fpage>199</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1007/s10858-005-4425-x</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schechter</surname> <given-names>M</given-names></name><name><surname>Grigoletto</surname> <given-names>J</given-names></name><name><surname>Abd-Elhadi</surname> <given-names>S</given-names></name><name><surname>Glickstein</surname> <given-names>H</given-names></name><name><surname>Friedman</surname> <given-names>A</given-names></name><name><surname>Serrano</surname> <given-names>GE</given-names></name><name><surname>Beach</surname> <given-names>TG</given-names></name><name><surname>Sharon</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson's disease</article-title><source>Molecular Neurodegeneration</source><volume>15</volume><elocation-id>24</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-020-00370-y</pub-id><pub-id pub-id-type="pmid">32228705</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schechter</surname> <given-names>M</given-names></name><name><surname>Atias</surname> <given-names>M</given-names></name><name><surname>Abd Elhadi</surname> <given-names>S</given-names></name><name><surname>Davidi</surname> <given-names>D</given-names></name><name><surname>Gitler</surname> <given-names>D</given-names></name><name><surname>Sharon</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>α-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate</article-title><source>Journal of Biological Chemistry</source><volume>295</volume><fpage>18076</fpage><lpage>18090</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA120.015319</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahmoradian</surname> <given-names>SH</given-names></name><name><surname>Lewis</surname> <given-names>AJ</given-names></name><name><surname>Genoud</surname> <given-names>C</given-names></name><name><surname>Hench</surname> <given-names>J</given-names></name><name><surname>Moors</surname> <given-names>TE</given-names></name><name><surname>Navarro</surname> <given-names>PP</given-names></name><name><surname>Castaño-Díez</surname> <given-names>D</given-names></name><name><surname>Schweighauser</surname> <given-names>G</given-names></name><name><surname>Graff-Meyer</surname> <given-names>A</given-names></name><name><surname>Goldie</surname> <given-names>KN</given-names></name><name><surname>Sütterlin</surname> <given-names>R</given-names></name><name><surname>Huisman</surname> <given-names>E</given-names></name><name><surname>Ingrassia</surname> <given-names>A</given-names></name><name><surname>Gier</surname> <given-names>Y</given-names></name><name><surname>Rozemuller</surname> <given-names>AJM</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Paepe</surname> <given-names>A</given-names></name><name><surname>Erny</surname> <given-names>J</given-names></name><name><surname>Staempfli</surname> <given-names>A</given-names></name><name><surname>Hoernschemeyer</surname> <given-names>J</given-names></name><name><surname>Großerüschkamp</surname> <given-names>F</given-names></name><name><surname>Niedieker</surname> <given-names>D</given-names></name><name><surname>El-Mashtoly</surname> <given-names>SF</given-names></name><name><surname>Quadri</surname> <given-names>M</given-names></name><name><surname>Van IJcken</surname> <given-names>WFJ</given-names></name><name><surname>Bonifati</surname> <given-names>V</given-names></name><name><surname>Gerwert</surname> <given-names>K</given-names></name><name><surname>Bohrmann</surname> <given-names>B</given-names></name><name><surname>Frank</surname> <given-names>S</given-names></name><name><surname>Britschgi</surname> <given-names>M</given-names></name><name><surname>Stahlberg</surname> <given-names>H</given-names></name><name><surname>Van de Berg</surname> <given-names>WDJ</given-names></name><name><surname>Lauer</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>1099</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0423-2</pub-id><pub-id pub-id-type="pmid">31235907</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snead</surname> <given-names>D</given-names></name><name><surname>Eliezer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Intrinsically disordered proteins in synaptic vesicle trafficking and release</article-title><source>Journal of Biological Chemistry</source><volume>294</volume><fpage>3325</fpage><lpage>3342</lpage><pub-id pub-id-type="doi">10.1074/jbc.REV118.006493</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulzer</surname> <given-names>D</given-names></name><name><surname>Edwards</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The physiological role of α-synuclein and its relationship to Parkinson's Disease</article-title><source>Journal of Neurochemistry</source><volume>150</volume><fpage>475</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1111/jnc.14810</pub-id><pub-id pub-id-type="pmid">31269263</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theillet</surname> <given-names>FX</given-names></name><name><surname>Binolfi</surname> <given-names>A</given-names></name><name><surname>Bekei</surname> <given-names>B</given-names></name><name><surname>Martorana</surname> <given-names>A</given-names></name><name><surname>Rose</surname> <given-names>HM</given-names></name><name><surname>Stuiver</surname> <given-names>M</given-names></name><name><surname>Verzini</surname> <given-names>S</given-names></name><name><surname>Lorenz</surname> <given-names>D</given-names></name><name><surname>van Rossum</surname> <given-names>M</given-names></name><name><surname>Goldfarb</surname> <given-names>D</given-names></name><name><surname>Selenko</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural disorder of monomeric α-synuclein persists in mammalian cells</article-title><source>Nature</source><volume>530</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1038/nature16531</pub-id><pub-id pub-id-type="pmid">26808899</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Vargas</surname> <given-names>KJ</given-names></name><name><surname>Colosi</surname> <given-names>PL</given-names></name><name><surname>Girardi</surname> <given-names>E</given-names></name><name><surname>Chandra</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>α-Synuclein facilitates clathrin assembly in synaptic vesicle endocytosis</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.04.29.069344</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varkey</surname> <given-names>J</given-names></name><name><surname>Isas</surname> <given-names>JM</given-names></name><name><surname>Mizuno</surname> <given-names>N</given-names></name><name><surname>Jensen</surname> <given-names>MB</given-names></name><name><surname>Bhatia</surname> <given-names>VK</given-names></name><name><surname>Jao</surname> <given-names>CC</given-names></name><name><surname>Petrlova</surname> <given-names>J</given-names></name><name><surname>Voss</surname> <given-names>JC</given-names></name><name><surname>Stamou</surname> <given-names>DG</given-names></name><name><surname>Steven</surname> <given-names>AC</given-names></name><name><surname>Langen</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>32486</fpage><lpage>32493</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.139576</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Várnai</surname> <given-names>P</given-names></name><name><surname>Balla</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and Agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools</article-title><source>Journal of Cell Biology</source><volume>143</volume><fpage>501</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1083/jcb.143.2.501</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westphal</surname> <given-names>CH</given-names></name><name><surname>Chandra</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Monomeric synucleins generate membrane curvature</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>1829</fpage><lpage>1840</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.418871</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname> <given-names>BG</given-names></name><name><surname>Mandad</surname> <given-names>S</given-names></name><name><surname>Truckenbrodt</surname> <given-names>S</given-names></name><name><surname>Kröhnert</surname> <given-names>K</given-names></name><name><surname>Schäfer</surname> <given-names>C</given-names></name><name><surname>Rammner</surname> <given-names>B</given-names></name><name><surname>Koo</surname> <given-names>SJ</given-names></name><name><surname>Claßen</surname> <given-names>GA</given-names></name><name><surname>Krauss</surname> <given-names>M</given-names></name><name><surname>Haucke</surname> <given-names>V</given-names></name><name><surname>Urlaub</surname> <given-names>H</given-names></name><name><surname>Rizzoli</surname> <given-names>SO</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins</article-title><source>Science</source><volume>344</volume><fpage>1023</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.1126/science.1252884</pub-id><pub-id pub-id-type="pmid">24876496</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zonderland</surname> <given-names>J</given-names></name><name><surname>Wieringa</surname> <given-names>P</given-names></name><name><surname>Moroni</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A quantitative method to analyse F-actin distribution in cells</article-title><source>MethodsX</source><volume>6</volume><fpage>2562</fpage><lpage>2569</lpage><pub-id pub-id-type="doi">10.1016/j.mex.2019.10.018</pub-id><pub-id pub-id-type="pmid">31763187</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.61951.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Brunger</surname><given-names>Axel T</given-names></name><role>Reviewing Editor</role><aff><institution>Stanford University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Eliezer</surname><given-names>David</given-names> </name><role>Reviewer</role><aff><institution>Weill Cornell Medical College</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>In this short report it is shown that phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 3,4,5-trisphosphate (PIP3), two highly acidic components of inner plasma membrane leaflets, mediate plasma membrane localization of endogenous pools of α-synuclein in A2780, HeLa, SH-SY5Y and SK-MEL-2 cells. Moreover, it is shown that PIP2 synthesizing kinases and hydrolyzing phosphatases can redistribute α-synclein in cells. In addition, structural details of the interactions of αSyn with PIP2 containing membranes have been revealed by NMR spectroscopy.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;α-Synuclein plasma membrane localization correlates with cellular phosphatidylinositol polyphosphate levels&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Olga Boudker as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: David Eliezer (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>The normal behavior and function of α-synuclein remain poorly understood, at least in part because the majority of studies of this protein focus on its pathological self-assembly and deposition, processes that are thought to be critical for its role in neurodegeneration. Whether or not the latter is true, an improved understanding of the cell biology of α-synuclein is necessary to clarify when and how this protein deviates from its normal physiological contexts during the course of disease. To that end, understanding the cellular localization of the protein, (which has remained highly controversial) and to explore how it is regulated (which has hardly been studied) are important goals that are addressed by this study. Given the importance of PIPs in membrane trafficking pathways, and the growing consensus that α-synuclein functions in the arena of synaptic vesicle trafficking, uncovering a role for PIPs in attracting α-synuclein to membranes is a significant contribution to our understanding of this protein.</p><p>In this short report it is shown that phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 3,4,5-trisphosphate (PIP3), two highly acidic components of inner PM leaflets, mediate plasma membrane localization of endogenous pools of αSyn in A2780, HeLa, SH-SY5Y and SK-MEL-2 cells. Although it is already known that αSyn binds to PIP2 and other anionic lipids and that this binding induces α-helicity in αSyn this work additionally shows that PIP2 synthesizing kinases and hydrolyzing phosphatases can redistribute αSyn in cells. Moreover, structural details of the interactions of αSyn with PIP2 containing membranes have been revealed by NMR spectroscopy.</p><p>Essential revisions:</p><p>While overall, there is good evidence that αSyn targets PIP2 at the plasma membrane, the in vivo relevance remains unclear, in particular with neuronal activity-dependent roles of PIP2 in both, synaptic vesicle exo- and endocytosis, and of PIP3 in postsynaptic receptor trafficking. The reviewers are concerned about the cellular systems that were chosen to assess αSyn plasma membrane localization – mostly of non-neuronal origin – which the authors also highlight themselves. The authors have the neuronal SH-SY5Y cell line and produced little data with this line, but most of the experiments presented here were performed in A2780 (ovarian carcinoma), HeLa (cervical cancer) and SK-MEL-2 (skin metastasis) cells. If some of the experiments could be repeated in the neuroblastoma cell line, ideally differentiated into a more neuron-like shape, it would make the paper more compelling.</p><p>Figure 1E and Figure 1—figure supplement 1B: The authors describe increased amounts of αSyn at the PM by expression of PIPKIγ. Are total αSyn levels affected, and could this result in an increased pool on the PM? Please test by western blotting.</p><p>Figure 1—figure supplement 1D: An overlay or quantification of the localization of αSyn at the PM would be helpful. The overlap in A2780 cells seems to be high, but the overlap in SH-SY5Y and SK-MEL-2 cells is not particularly convincing.</p><p>Figure 2C: Please justify the use of 100 nm vesicles. If the PM should be mimicked, the vesicles should have a larger diameter.</p><p>Figure 3A: The quantification of αSyn intensity with expression of INPP5E is not reflected by the provided image where there is essentially no αSyn signal. Please provide a more representative image.</p><p>Figure 3A: The authors argue that αSyn has a specificity for PIP2 and PIP3, but why then are there no apparent changes between αSyn intensity upon expression of MTM1 and INPP5E (which result in production of π and PI4P, respectively) versus PTEN (which produces PIP2 from PIP3)? In addition, the authors describe that &quot;only the conversion of PIP2 to PI4P by INPP5E led to a marked reduction&quot; but their statistics show significant changes for all three phosphatases compared to mCherry only.</p><p>Figure 3: There may be a contribution of coincidental labeling. Could the authors reduce PIP2 and/or PIP3 levels as in panel 3A and repeat their analysis?</p><p>Are the observed CD spectra and NMR spectra shown in Figure 2 consistent with residues ~ 1-100 in an helical conformation and the remaining ~ 40 residues being unstructured under high PIP2 to αSyn ratios, similar to the solution NMR structure of micelle-bound αSyn (PDB ID 1XQ8) or similar to the solid state NMR studies of αSyn interactions with lipid bilayers by Fuso et al., Nature Comm, 2014? In other words, are residues 100-140 unstructured in all these studies? Please comment.</p><p>The experiments with calcium (Figure 2E) suggest that the first ten residues always interact with PC-PIP2 vesicles, although overall binding was greatly reduced. However, plasma membranes contain anionic lipids that may mitigate the effect of calcium that is observed in these experiments. Please comment.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.61951.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>While overall, there is good evidence that αSyn targets PIP2 at the plasma membrane, the in vivo relevance remains unclear, in particular with neuronal activity-dependent roles of PIP2 in both, synaptic vesicle exo- and endocytosis, and of PIP3 in postsynaptic receptor trafficking. The reviewers are concerned about the cellular systems that were chosen to assess αSyn plasma membrane localization – mostly of non-neuronal origin – which the authors also highlight themselves. The authors have the neuronal SH-SY5Y cell line and produced little data with this line, but most of the experiments presented here were performed in A2780 (ovarian carcinoma), HeLa (cervical cancer) and SK-MEL-2 (skin metastasis) cells. If some of the experiments could be repeated in the neuroblastoma cell line, ideally differentiated into a more neuron-like shape, it would make the paper more compelling.</p></disp-quote><p>We have now included new figure panels depicting co-localization of endogenous αSyn with PIP2 in fully differentiated SH-SY5Y cells. Specifically, we followed a 14-day differentiation protocol that employs initial stimulation with retinoic acid (RA) for 5 days, followed by brain-derived neurotrophic factor (BDNF) treatment for 7 additional days. The procedure commonly accepted as the most stringent differentiation routine for SH-SY5Y cells<sup>1</sup>, especially in comparison to differentiation with RA only<sup>2</sup>. In line with expected results, we observed substantial neurite outgrowth and shrinkage of cell bodies, concomitant with increased expression of endogenous αSyn (new Figure 1—figure supplement 1C). We detected αSyn in cell bodies and neurites, although protein pools were particularly abundant along neurites where they colocalize with PIP2 in expanded structures reminiscent of synaptic boutons (new Figure 1C, D, lower panel). Indeed, co-staining for the vesicular SNARE-component synaptobrevin-2 (Syb2/VAMP2) confirmed that αSynPIP2 and αSyn-Syb2/VAMP2 localize to these structures (new Figure 1—figure supplement 1D, E). As the reviewers are obviously aware, Syb2/VAMP2 is one of the few “broadly accepted” binding partners of αSyn in presynaptic terminals<sup>3</sup>.</p><p>To the best of our knowledge, these are the first reported results of endogenous αSyn-PIP2 and Syb2/VAMP colocalization in fully differentiated SH-SY5Y cells.</p><p>We updated the manuscript accordingly:</p><p>Abstract: “… endogenous pools of αSyn in A2780, HeLa, SK-MEL-2 and differentiated and undifferentiated neuronal SH-SY5Y cells.”</p><p>Results: “We verified PM colocalization of αSyn with PIP<sub>2</sub> in SH-SY5Y cells that we differentiated into dopaminergic-like neurons following a stringent protocol and stimulation with retinoic acid (RA) and brain-derived neurotrophic factor (BDNF)<sup>1</sup> (Figure 1—figure supplement 1C). We found prominent pools of αSyn in expanded structures reminiscent of synaptic boutons along neurites, where they colocalized with PIP<sub>2</sub> (Figure 1C, bottom panel, Figure 1D and Figure 1—figure supplement 1D). These structures also stained positive for the presynaptic V-SNARE component syanptobrevin2/VAMP2, a known binding partner of αSyn<sup>3</sup> (Figure 1—figure supplement 1E).”</p><p>We also attempted to transfect fully differentiated SH-SY5Y cells with GFP-PIPKIγ to ask whether ectopic expression of the PIP2 kinase triggered localization of higher levels of endogenous αSyn at the PM. This is a challenging experiment in any kind of terminally differentiated cell line. We accomplished this goal after careful evaluation of various transfection agents and procedures. However, we were unable to perform consistent confocal imaging at equivalent planes for cell bodies and neurites given their highly irregular shapes and extended morphologies. Accordingly, we did not quantify αSynfluorescence on a per cell basis in <italic>differentiated SH-SY5Y cells</italic>, as we had done for A2780 and HeLa cells.</p><p>Instead, we extended the analysis of induced αSyn PM localization upon PIPKIγ expression in <italic>undifferentiated SH-SY5Y cells</italic>, which is now included in the new Figure 1E (right panel). Compared to the original submission, we increased the number of analyzed cells (n &gt; 120) to derive quantitative information about the significance of the observed effect. We are happy to report that we obtained <italic>p</italic>-values &lt; 0.001 (***) for this and all other cell lines indicating the general significance and reproducibility of the PMtargeting effect upon induced accumulation of PIP2 at the PM. We moved the analysis of HeLa cells to Figure 1—figure supplement 2A.</p><p>We updated the manuscript accordingly (see also the next question).</p><p>Results: “We obtained similar results in undifferentiated SH-SY5Y and HeLa cells (Figure 1E and Figure 1—figure supplement 2A) and confirmed that transient</p><p>PIPKIγ expression did not affect overall αSyn abundance (Figure 1—figure supplement 2B).”</p><disp-quote content-type="editor-comment"><p>Figure 1E and Figure 1—figure supplement 1B: The authors describe increased amounts of αSyn at the PM by expression of PIPKIγ. Are total αSyn levels affected, and could this result in an increased pool on the PM? Please test by western blotting.</p></disp-quote><p>We quantified levels of endogenous αSyn in A2780 and undifferentiated SHSY5Y cells upon expression of wild-type (WT) GFP-PIPKIγ and GFP only. In addition, we included two PIPKIγ mutants (D316A and K188A), which are catalytically inactive but targeted to the PM similar to WT PIPKIγ. As can be appreciated from the Western blots (new Figure 1 —figure supplement 2B), transient expression of any of these constructs did not alter the global levels of endogenous αSyn. We include this analysis in the revised manuscript and updated the text accordingly (see above).</p><disp-quote content-type="editor-comment"><p>Figure 1—figure supplement 1D: An overlay or quantification of the localization of αSyn at the PM would be helpful. The overlap in A2780 cells seems to be high, but the overlap in SH-SY5Y and SK-MEL-2 cells is not particularly convincing.</p></disp-quote><p>There appears to be a misunderstanding as to what the PM-dye in these images shows. This panel confirms that the chosen TIRF fields correctly represent the PM, which is identified by staining with tetramethylrhodamine-WGA (as specified in the figure legend). No co-localization between this dye and αSyn is expected. The dye simply identifies the basal plane of the PM, whereas αSyn signals show pools of endogenous protein at the PM and cell type-specific variations thereof. Brighter patches of PM-dye correspond to preferred incorporation of tetramethylrhodamine-WGA, which does not correlate with (nor represent) PIP2 or αSyn localization. Irrespectively, we selected new image panels to better reflect unrelated WGA and αSyn “staining” in the revised figure (now Figure 1—figure supplement 2C)</p><disp-quote content-type="editor-comment"><p>Figure 2C: Please justify the use of 100 nm vesicles. If the PM should be mimicked, the vesicles should have a larger diameter.</p></disp-quote><p>While we share the reviewer’s concern regarding the (implied) “curvature” aspect of 100 nm vesicles versus larger, giant unilamellar vesicles (GUVs) with a diameter &gt; 1 µm, PIP2-containing GUVs are inherently unstable in the presence of low µM amounts of Ca<sup>2+</sup> and rupture within minutes<sup>4</sup>, thus precluding experiments presented in Figure 2E. Despite these shortcomings, we believe that 100 nm vesicles (i.e. LUVs) represent excellent surrogates for studying αSyn interactions with “planar” membranes.</p><p>Considering the geometries of αSyn and target vesicles as spherical in a first approximation, αSyn molecules approaching these membranes display the following properties:</p><fig id="sa2fig1"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61951-resp-fig1-v2.tif"/></fig><p>Given the known diameter of αSyn in solution (~6 nm<sup>5, 6</sup>) and that of our reconstituted vesicles (i.e. ~100 nm), the local interaction surface displays minimal curvature over the entire dimensions of the protein (indicated by arrow heads). Because αSyn residues 1-12 act as the primary anchoring sites<sup>7, 8</sup>, the extension of the corresponding α-helix (~1.6 nm) can be extracted from available experimental data<sup>9</sup>. As can be appreciated in <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>, curvature is negligible over this range of dimensions and initial contacts between αSyn monomers and 100 nm vesicles or planar membranes are virtually identical on the microscopic level. Even in the fully extended helical conformation, spanning roughly 12 nm<sup>10</sup>, curvature effects imposed by 100 nm vesicles are small (not taking membrane bending and remodeling activities by αSyn into account<sup>11</sup>).It is also important to keep in mind that in today’s discussions about αSyn-membrane interactions, “membrane curvature” mostly serves as a proxy for “lipid packing defects”. While it is clear that high curvature induces/exacerbates these defects and enhances αSyn binding, membrane fluidity and composition especially with regard to saturated versus unsaturated fatty acids (FA) act as important additional contributors to packing defects. In this regard, we believe that the poly-unsaturated FA character of most PIPs and induced packing defects exert a stronger influence than curvature itself.</p><disp-quote content-type="editor-comment"><p>Figure 3A: The quantification of αSyn intensity with expression of INPP5E is not reflected by the provided image where there is essentially no αSyn signal. Please provide a more representative image.</p></disp-quote><p>This has been updated and we now provide an image that better reflects residual amounts of endogenous αSyn at the PM upon INPP5E overexpression (new panel in Figure 3A). Specifically, we have chosen a comparative view that shows cells <italic>not</italic> transfected with INPP5E-mCherry (upper left, lower right corners) together with a transfected one in the same frame (center). The differences in PM-localization levels of endogenous αSyn are readily evident (see also Q6 next).</p><disp-quote content-type="editor-comment"><p>Figure 3A: The authors argue that αSyn has a specificity for PIP2 and PIP3, but why then are there no apparent changes between αSyn intensity upon expression of MTM1 and INPP5E (which result in production of π and PI4P, respectively) versus PTEN (which produces PIP2 from PIP3)? In addition, the authors describe that &quot;only the conversion of PIP2 to PI4P by INPP5E led to a marked reduction&quot; but their statistics show significant changes for all three phosphatases compared to mCherry only.</p></disp-quote><p>We fully agree with the reviewer that our <italic>p</italic>-value analysis and corresponding statistical significance (** versus ***) were at odds with our statement. As a matter of fact, they were also at odds with what is shown in the whisker blots (of Figure 3A), as mCherryctrl and MTM1, PTEN datasets were obviously <italic>too similar</italic> to rationalize the low <italic>p</italic>-values. We revisited the source data file and recalculated <italic>p</italic>-values. Indeed, we found that the mCherry-ctrl – MTM1 comparison yields a <italic>p</italic>-value of 0.6297. Therefore, the correct labeling should have been <italic>“not significant”</italic> (NS).</p><p>The <italic>p</italic>-value for the mCherry-ctrl – PTEN is 0.0198, thus should have been labeled * (<italic>p</italic> &lt; 0.05). Upon closer inspection, we realized that the significance analysis in this particular case, is dominated by the spread of data points in the control dataset compared to the phosphatase experiments and, therefore, should be considered with caution. By excluding single high-value outliers in the mCherry-ctrl dataset (by adjusting the overall threshold), we learned that the INPP5E experiment displayed the only “robust” value (*** <italic>p</italic> &lt; 0.001).</p><p>We rechecked all other <italic>p</italic>-values and now include them in the revised source data files.</p><p>In summary, we had mislabeled the significance values in our original submission and updated the figure accordingly. Having made those changes, we believe that our initial statement “In agreement with our hypothesis, only the conversion of PIP<sub>2</sub> to PI(4)P by INPP5E led to a marked reduction of endogenous αSyn at the PM (Figure 3A).” remains valid. We kept the original wording in the revised versions of the manuscript.</p><disp-quote content-type="editor-comment"><p>Figure 3: There may be a contribution of coincidental labeling. Could the authors reduce PIP2 and/or PIP3 levels as in panel 3A and repeat their analysis?</p></disp-quote><p>Coincidental labeling between PIP2 and PIP3 can be excluded due to the fact that PIP2 detection is antibody-mediated, whereas PIP3 identification is accomplished via transient expression of the GRP1-PH-domain fused to GFP. The affinity of GRP1-PH domain towards PIP3 is 2-3 orders of magnitudes greater than for PIP2, and negligible for other PIPs<sup>12</sup>. Hence, “PIP3-fluorescence” originates from interaction of a PH domain that specifically recognizes PIP3 only. Technically speaking, no cross-reactivity is possible in such a system. We believe that this notion is corroborated by the differential appearance of PIP2 and PIP3 signals in the time course. At 120 seconds, for instance, endogenous αSyn localization “follows” the PIP3 signal, whereas PIP2 fluorescence is virtually absent (Figure 3B). In that sense, we are confident that our experimental setup cleanly reports on signaling mediated redistributions of cellular αSyn in a manner that is PIP2 and PIP3-dependent.</p><disp-quote content-type="editor-comment"><p>Are the observed CD spectra and NMR spectra shown in Figure 2 consistent with residues ~ 1-100 in an helical conformation and the remaining ~ 40 residues being unstructured under high PIP2 to αSyn ratios, similar to the solution NMR structure of micelle-bound αSyn (PDB ID 1XQ8) or similar to the solid state NMR studies of αSyn interactions with lipid bilayers by Fuso et al., Nature Comm, 2014? In other words, are residues 100-140 unstructured in all these studies? Please comment.</p></disp-quote><p>Yes, based on available NMR spectra (Figure 2B and Figure 2—figure supplement 1A and 2B), it is evident that resonances corresponding to residues 100-140, do not undergo line-broadening and do not display chemical shift changes, i.e., superimpose perfectly with those of disordered monomeric αSyn. This corroborates that C-terminal residues remain dynamic and disordered upon PIP2-vesicle binding, similar to all previously determined αSyn-membrane interactions. To strengthen this notion, we modified the text at several points:</p><p>Results: “Together, these results established that residues 1-100 of αSyn interacted with PIP<sub>2</sub>vesicles in helical conformations that imposed membrane remodeling, whereas C-terminal residues 100-140 did not engage in membrane-binding and remained flexible and disordered.”</p><p>Discussion: “… these interactions are indistinguishable from other previously identified, negatively charged membrane systems with primary contacts by N-terminal αSyn residues 1-10 and progressively weaker interactions along residues 10-100. Cterminal residues 100-140 are not involved in PIP<sub>2</sub> membrane binding, similar to all other reconstituted vesicular or planar lipid surface interactions studied thus far.”</p><disp-quote content-type="editor-comment"><p>The experiments with calcium (Figure 2E) suggest that the first ten residues always interact with PC-PIP2 vesicles, although overall binding was greatly reduced. However, plasma membranes contain anionic lipids that may mitigate the effect of calcium that is observed in these experiments. Please comment.</p></disp-quote><p>Yes, this is exactly what we intended to recapitulate in this experiment. As outlined in Materials and methods, we used 60 µM of isotope-labeled (<sup>15</sup>N) αSyn and a 50fold <italic>mass</italic> excess of PC-PIP2 vesicles. In molar terms, this corresponds to ~41.25 mM of total lipids and ~2.95 mM of PIP2 given the molar ratio between DOPC:PIP2 of 13:1. We added Ca<sup>2+</sup> to a final concentration of 2.5 mM. However, membrane-embedded PIP2 can sequester up to 3 Ca<sup>2+</sup> ions per lipid (3:1)<sup>13</sup>, which indicates that Ca<sup>2+</sup> is present at substoichiometric amounts with respect to direct PIP2 binding, but in large excess to αSyn.</p><p>When αSyn binds to membranes in its characteristic extended helical conformation, it coordinates between 20-30 lipid molecules, depending on lipid type and clustering<sup>14, 15</sup>. If αSyn were to <italic>only</italic> interact with PIP2 molecules on DOPC:PIP2 vesicles, this would translate into 1.2-1.8 mM of PIP2 (at 60 µM of αSyn) and, accordingly, reduce the concentration of membrane-embedded PIP2 not bound by αSyn to 1.75-1.15 mM. At 3:1 of Ca<sup>2+</sup>:PIP2 binding, all of the added Ca<sup>2+</sup> could coordinate free PIP2 on DOPC:PIP2 vesicles and <italic>not</italic> displace any of the PIP2-bound αSyn. As our results show, this is clearly not the case, i.e. C-terminal portions of αSyn <italic>are</italic> effectively displaced by Ca<sup>2+</sup>.</p><p>This strongly argues for a scenario in which αSyn actively clusters PIP2 on the surface of DOPC:PIP2 vesicles (in line with MD simulations <sup>16</sup>). These PIP2 clusters likely exhibit higher affinity for Ca<sup>2+</sup> than the remaining portions of non-clustered PIP2. As a result, Ca<sup>2+</sup> progressively displaces parts of αSyn that exhibit weaker PIP2 interactions (i.e. residues 10100) whereas regions of higher PIP2 affinity are unaffected and remain vesicle-bound (i.e. residues 1-10). In that sense, PIP2 clustering by αSyn is “replaced” by protein-independent divalent metal coordination after the addition of Ca<sup>2+17</sup>. Thus, our experimental setup effectively recapitulates a competitive binding scenario in which “physiological” amounts of Ca<sup>2+</sup> (within the range of synaptic transmission, for example) compete for anionic lipid interactions with membrane-bound proteins-, in our case αSyn-, that are present at substoichiometric concentrations. This is in line with expected, general behaviors of PIP2 micro-domains in biology<sup>18</sup>.</p><p>We did not dwell on this aspect in the original submission because we consider it is outside the scope of the manuscript. We are grateful for being able to communicate it here so that readers can access it in the published <italic>Author Response</italic>.</p><p>References</p><p>Encinas M<italic>, et al.</italic> Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. <italic>J Neurochem</italic> 75, 991-1003 (2000).</p><p>Lopes FM<italic>, et al.</italic> Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. <italic>Brain Res</italic> 1337, 85-94 (2010).</p><p>Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC. Α-synuclein promotes SNARE-complex assembly in vivo and in vitro. <italic>Science</italic> 329, 1663-1667 (2010).</p><p>Carvalho K, Ramos L, Roy C, Picart C. Giant unilamellar vesicles containing phosphatidylinositol(4,5)bisphosphate: characterization and functionality. <italic>Biophys J</italic> 95, 4348-4360 (2008).</p><p>Paleologou KE<italic>, et al.</italic>Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein. <italic>J Biol Chem</italic> 283, 16895-16905 (2008).</p><p>Stephens AD, Nespovitaya N, Zacharopoulou M, Kaminski CF, Phillips JJ, Kaminski Schierle GS. Different Structural Conformers of Monomeric α-Synuclein Identified after Lyophilizing and Freezing. <italic>Anal Chem</italic> 90, 6975-6983 (2018).</p><p>Bodner CR, Dobson CM, Bax A. Multiple tight phospholipid-binding modes of α-synuclein revealed by solution NMR spectroscopy. <italic>J Mol Biol</italic> 390, 775-790 (2009).</p><p>Lokappa SB, Suk JE, Balasubramanian A, Samanta S, Situ AJ, Ulmer TS. Sequence and membrane determinants of the random coil-helix transition of α-synuclein. <italic>J Mol Biol</italic> 426, 2130-2144 (2014).</p><p>Fusco G, De Simone A, Arosio P, Vendruscolo M, Veglia G, Dobson CM. Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity. <italic>Sci Rep</italic> 6, 27125 (2016).</p><p>Jao CC, Hegde BG, Chen J, Haworth IS, Langen R. Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement. <italic>Proc Natl Acad Sci U S A</italic> 105, 19666-19671 (2008).</p><p>West A, Brummel BE, Braun AR, Rhoades E, Sachs JN. Membrane remodeling and mechanics: Experiments and simulations of α-Synuclein. <italic>Biochim Biophys Acta</italic> 1858, 1594-1609 (2016).</p><p>Kavran JM<italic>, et al.</italic> Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains. <italic>J Biol Chem</italic> 273, 30497-30508 (1998).</p><p>Bradley RP, Slochower DR, Janmey PA, Radhakrishnan R. Divalent cations bind to phosphoinositides to induce ion and isomer specific propensities for nano-cluster initiation in bilayer membranes. <italic>R Soc Open Sci</italic> 7, 192208 (2020).</p><p>Galvagnion C<italic>, et al.</italic> Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation. <italic>Nat Chem Biol</italic> 11, 229-234 (2015).</p><p>Middleton ER, Rhoades E. Effects of curvature and composition on α-synuclein binding to lipid vesicles. <italic>Biophys J</italic> 99, 2279-2288 (2010).</p><p>Gambhir A<italic>, et al.</italic> Electrostatic sequestration of PIP2 on phospholipid membranes by basic/aromatic regions of proteins. <italic>Biophys J</italic> 86, 2188-2207 (2004).</p><p>Wang YH, Slochower DR, Janmey PA. Counterion-mediated cluster formation by polyphosphoinositides. <italic>Chem Phys Lipids</italic> 182, 38-51 (2014).</p><p>Borges-Araujo L, Fernandes F. Structure and Lateral Organization of Phosphatidylinositol 4,5bisphosphate. <italic>Molecules</italic> 25, (2020).</p></body></sub-article></article>